KR100962587B1 - A method for fermentation of natural plants and herbal medicines, a fermented product prepared therefrom and a paharmaceutical composition, a cosmetic compositon and a food composition comprising the product - Google Patents
A method for fermentation of natural plants and herbal medicines, a fermented product prepared therefrom and a paharmaceutical composition, a cosmetic compositon and a food composition comprising the product Download PDFInfo
- Publication number
- KR100962587B1 KR100962587B1 KR1020070099512A KR20070099512A KR100962587B1 KR 100962587 B1 KR100962587 B1 KR 100962587B1 KR 1020070099512 A KR1020070099512 A KR 1020070099512A KR 20070099512 A KR20070099512 A KR 20070099512A KR 100962587 B1 KR100962587 B1 KR 100962587B1
- Authority
- KR
- South Korea
- Prior art keywords
- fermentation
- natural plant
- plant material
- herbal medicine
- yeast
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Birds (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
누룩 및 유산균을 이용한 천연 식물소재 및 한약재의 발효방법, 상기 방법에 의해서 제조된 발효물 및 이를 함유하는 화장품 조성물 및 식품 조성물이 제공된다.Provided are fermentation methods of natural plant materials and herbal medicines using Nuruk and lactic acid bacteria, fermented products prepared by the above methods, and cosmetic compositions and food compositions containing the same.
본 발명에 따르면, 일상 생활에서 용이하게 섭취가능한 천연 식물성 소재나 생리활성이 강하여 한의학에서 사용되는 한약재를 누룩 및 유산균을 이용하여 발효시킴으로써 별도의 탄소원 첨가 없이도 유산균 발효 효율을 높일 수 있으며, 제조된 발효물은 안정성 및 안전성이 매우 뛰어나고 우수한 항노화, 항암, 항염, 면역 개선 등의 효능을 갖기 때문에 약학 조성물, 화장품 조성물 및 식품 조성물 등에 유용하게 포함될 수 있는, 천연 식물소재 및 한약재의 발효방법, 상기 방법에 의해서 제조된 발효물 및 이를 함유하는 약학 조성물, 화장품 조성물 및 식품 조성물을 제공할 수 있다.According to the present invention, it is possible to increase the fermentation efficiency of lactic acid bacteria without the addition of a carbon source by fermenting a natural plant material or a physiological activity that is easily ingested in daily life and using medicinal herbs used in oriental medicine using Nuruk and lactic acid bacteria. Since water is very stable and safe and has excellent efficacy of anti-aging, anticancer, anti-inflammatory, and immunity, it may be usefully used in pharmaceutical compositions, cosmetic compositions and food compositions, fermentation methods of natural plant materials and herbal medicines, the method It can be provided a fermentation product prepared by and a pharmaceutical composition, a cosmetic composition and a food composition containing the same.
Description
본 발명은 누룩 및 유산균을 이용한 천연 식물소재 및 한약재의 발효방법, 상기 방법에 의해서 제조된 발효물 및 이를 함유하는 화장품 조성물 및 식품 조성물에 관한 것으로서, 더욱 구체적으로는 일상 생활에서 용이하게 섭취가능한 천연 식물성 소재나 생리활성이 강하여 한의학에서 사용되는 한약재를 누룩 및 유산균을 이용하여 발효시킴으로써 별도의 탄소원 첨가 없이도 유산균 발효 효율을 높일 수 있으며, 제조된 발효물은 안정성 및 안전성이 매우 뛰어나고 우수한 항노화, 항암, 항염, 면역 개선 등의 효능을 갖기 때문에 약학 조성물, 화장품 조성물 및 식품 조성물 등에 유용하게 포함될 수 있는, 천연 식물소재 및 한약재의 발효방법, 상기 방법에 의해서 제조된 발효물 및 이를 함유하는 약학 조성물, 화장품 조성물 및 식품 조성물에 관한 것이다.The present invention relates to a fermentation method of natural plant materials and herbal medicines using Nuruk and lactic acid bacteria, fermented products prepared by the above method, and cosmetic compositions and food compositions containing the same, more specifically, natural foods that are easily ingested in daily life. By fermenting herbal medicine used in oriental medicine with yeast and lactic acid bacteria because of strong vegetable material or physiological activity, lactic acid bacteria fermentation efficiency can be increased without adding carbon source, and the prepared fermented products have excellent stability and safety, and have excellent anti-aging and anticancer activity. , Anti-inflammatory, immunity improvement, etc., which can be usefully included in pharmaceutical compositions, cosmetic compositions and food compositions, fermentation methods of natural plant materials and herbal medicines, fermented products prepared by the method and pharmaceutical compositions containing the same, Of cosmetic compositions and food compositions to be.
최근 고령화 사회의 도래로 웰빙 트랜드가 사회 전반에 뿌리내리고 있으며, 이는 식품, 화장품, 주거 환경 등의 모든 분야에서 천연 식물성 소재 및 전통적인 민간 요법으로 전래되는 한약재에 대한 관심을 증폭시켰다.With the advent of an aging society in recent years, well-being trends are taking root throughout the society, which has amplified the interest in herbal medicines that have been introduced to natural vegetable materials and traditional folk remedies in all fields such as food, cosmetics, and residential environment.
상대적으로 천연 식물소재의 제품화가 용이한 화장품 산업 분야에서 오래전부터 이를 원료로 사용한 시도들이 있어 왔으며, 기능식품 및 예방의학, 치료의학의 분야에서도 동양의 식물성 약재 (Herbal medicine)가 미국 및 유럽에서까지 허가 및 제품화되기 시작하면서, 천연 식물소재 및 한약재의 인체 유용성에 대한 관심이 증가하였다.In the cosmetics industry, where natural plant materials are relatively easy to commercialize, there have been attempts to use them as raw materials for a long time. In the fields of functional foods, preventive medicine and therapeutic medicine, oriental herbal medicine has been used in the US and Europe. As licensing and commercialization began, interest in the human utility of natural plant materials and herbal medicines increased.
천연 식물소재 또는 한약재는 다양한 생리활성 물질과 항산화 물질을 함유하고 있어 항노화, 항암, 항염, 면역 기능 개선 등 다양한 효과를 보이지만, 추출된 이후에는 불안정하고 때론 자극적이어서, 인체에 독성을 띄는 경우도 종종 있다. 따라서, 최근에는 천연 추출물을 안정화시키거나, 독성을 줄이거나, 안정한 유도체로 전환시켜 효과를 높이려는 시도가 많이 진행되고 있으며, 그 일환으로 미생물이나 효소를 이용한 생물학적 전환 (Biological transformation) 방법이 개발되고 있으며, 대표적 방법으로 발효를 예로 들 수 있다.Natural plant material or herbal medicine contains various biologically active substances and antioxidants, so it shows various effects such as anti-aging, anti-cancer, anti-inflammatory and immune function improvement, but it is unstable and sometimes irritating after extraction, so it is toxic to human body. Often. Therefore, in recent years, many attempts have been made to stabilize the natural extracts, reduce their toxicity, or convert them into stable derivatives to increase their effectiveness. As a part, biological transformation methods using microorganisms or enzymes have been developed. Representative methods include fermentation as an example.
발효는 미생물이 가지고 있는 효소를 이용하여 유기물을 분해시켜서 인간 생활에 유용하게 사용되는 물질을 제조하는 과정으로서, 인체에 유용한 물질을 만들어내는 대표적인 발효 미생물로는 유산균, 효모 등이 있고, 다양한 식품들이 발효 과정에 의해서 생산된다. 또한, 발효는 유용 물질을 만들어 내는 것 이외에도 발효에 관여하는 유산균이 장 내에서 면역 및 독소제거 (Detoxification)의 역할을 담당하기도 한다. 더 나아가, 장내 미생물에 의한 발효를 통해 섭취된 성분은 분해되어 인체 세포에 흡수가 용이한 저분자 물질로 전환되거나, 불안정하거나 불활성인 형태에서 활성 형태로 전환되어 흡수되기도 하며, 이러한 결과는 장내 미생물에 의한 생물전환의 중요성을 단적으로 보여주는 것이라 볼 수 있다.Fermentation is a process of producing a substance that is useful for human life by decomposing organic substances using enzymes of microorganisms. Representative fermentation microorganisms that produce substances useful for the human body include lactic acid bacteria, yeast, and various foods. Produced by fermentation process. In addition to producing useful substances, fermentation also plays a role in immunity and detoxification by the lactic acid bacteria involved in fermentation. Furthermore, the components ingested through fermentation by the intestinal microorganisms are decomposed and converted into low-molecular substances that are easily absorbed by human cells, or converted into unstable or inactive forms in the active form, which is absorbed by the intestinal microorganisms. This shows the importance of biotransformation.
따라서, 유산균 및 효모 등의 미생물 발효에 의해서 천연 식물소재 및 한약재의 효능을 극대화시키거나, 안전성 문제를 해결하기 위한 시도는 다양한 식품, 화장품, 약품 등의 개발에 있어서 중요한 의미를 갖는다 하겠다. 특히, 우수한 항암 효과, 항염증 효과, 항노화 효과, 면역력 증강 효과 등을 갖는 것으로 보고되는 김치나 된장 등의 한국전통식품에서 번식하는 미생물은 생물학적 활성이 뛰어난 것으로 보고되고 있어, 전통 발효 식품에서 분리한 미생물을 이용하려는 많은 연구가 진행되고 있다.Accordingly, attempts to maximize the efficacy of natural plant materials and herbal medicines or solve safety problems by microbial fermentation such as lactic acid bacteria and yeast have important meanings in the development of various foods, cosmetics, medicines and the like. In particular, the microorganisms that propagate in traditional Korean foods such as Kimchi and Doenjang, which are reported to have excellent anticancer effect, anti-inflammatory effect, anti-aging effect, and immunity enhancing effect, are reported to have excellent biological activity and are isolated from traditional fermented foods. Many studies are underway to exploit a microbe.
한국전통식품에서 번식하는 미생물의 일종인 누룩은 우리나라에서 예로부터 술을 제조하는데 이용되어 왔다. 누룩은 술을 만드는 효소를 갖는 곰팡이를 곡류에 번식시킨 것인데, 누룩의 주된 역할은 쌀과 같은 전분질 원료를 당화시키는 것으로서, 원시시대에는 술을 만들기 위해서 타액의 아밀라제를 이용하였지만, 이후 곰팡이 균사를 입힌 누룩을 사용하거나 보리를 침지하여 싹을 나게 한 맥아를 사용하는 방법이 보급되었다. 현재의 누룩은 주균인 라이조푸스 (Rhyzopus), 우사미 (Usami) 및 오리재 (Oryzae) 등의 균을 배양하여 구연산과 당화력을 높인 것들이 널리 사용되고 있다.Nuruk, a kind of microorganism that propagates in Korean traditional food, has been used to make alcohol in Korea since ancient times. Nuruk is a fungus with alcohol-producing fungi that grows in cereals. The main role of nuruk is to saccharify starch-like raw materials such as rice. In the primitive age, salivary amylase was used to make sake, but later fungal mycelium was applied. The use of yeast or malt that has sprouted by dipping barley has become popular. Currently, Nuruk is widely used to increase citric acid and glycosylation by cultivating bacteria such as the main strains Rhyzopus, Usami and Oryzae.
종래의 천연 식물소재 및 한약재를 이용한 기술들은 대부분 단순 추출물, 초 임계 추출물, 다양한 용매를 사용한 추출물을 사용하는 것들이지만, 일부 이러한 천연 식물소재 및 한약재에 대해서 누룩 곰팡이 또는 유산균을 사용하여 발효 과정을 수행하는 기술들이 개시된 바도 있다. 예를 들어, 대한민국 공개특허공보 제2005-64688호는 건강음료를 제조하는데 있어서, 볏짚을 사용하여 누룩 곰팡이가 번식되도록 함으로써 콩을 발효시키고 추출하는 발명을 개시하고 있으며, 대한민국 공개특허공보 제2007-6960호에서는 녹두를 유산균으로 발효시킴으로써 제조되는 화장료 조성물을 개시하고 있다.Conventional natural plant materials and herbal medicine techniques are mostly using simple extracts, supercritical extracts, extracts using a variety of solvents, but some of these natural plant materials and herbal medicines are carried out fermentation process using yeast fungi or lactic acid bacteria Techniques have been disclosed. For example, Korean Patent Laid-Open Publication No. 2005-64688 discloses an invention for fermenting and extracting soybean by allowing yeast mold to be propagated using rice straw in preparing a health beverage. No. 6960 discloses a cosmetic composition prepared by fermenting mung beans with lactic acid bacteria.
그러나, 천연 식물소재 및 한약재는 그 종류에 따라 다양한 성분들이 함유되어 있으며, 이 중에서 항균 성분이 많이 존재하는 소재 또는 미생물이 이용하기 용이한 형태의 탄소원을 많이 함유하고 있지 않은 소재의 경우에는 유산균을 접종하여 발효를 수행하여도 반응이 잘 수행되지 않는다. 이러한 문제의 해결을 위해서, 별도의 탄소원을 공급해 주거나, 정제 효소를 따로 사용하는 방법도 개발된 바 있으나, 여러 효소를 따로따로 첨가해야 하므로 공정이 복잡해지고, 경제적으로도 불리하다는 문제점이 있었다.However, natural plant materials and herbal medicines contain various components according to their types, and among them, materials containing a lot of antimicrobial ingredients or materials containing no carbon source in a form easily used by microorganisms may contain lactic acid bacteria. Even if the fermentation is performed by inoculation, the reaction is not performed well. In order to solve this problem, a method of supplying a separate carbon source or using a purified enzyme has been developed. However, since several enzymes have to be added separately, the process is complicated and economically disadvantageous.
따라서, 본 발명이 해결하고자 하는 첫 번째 과제는, 누룩을 이용한 당화 단계 및 유산균에 의한 발효 단계를 효과적으로 연계시킴으로써, 별도의 탄소원 첨가 없이도 유산균 발효 효율을 극대화할 수 있는 천연 식물소재 및 한약재의 발효방법을 제공하는 것이다.Therefore, the first problem to be solved by the present invention, by effectively linking the saccharification step using the yeast and fermentation step by lactic acid bacteria, fermentation method of natural plant material and herbal medicine that can maximize the lactic acid bacteria fermentation efficiency without the addition of additional carbon source To provide.
본 발명이 해결하고자 하는 두 번째 과제는, 안정성 및 안전성이 매우 뛰어나고 우수한 항노화, 항암, 항염, 면역 개선 등의 효능을 갖는, 상기 방법에 의해서 제조된 발효물을 제공하는 것이다.The second problem to be solved by the present invention is to provide a fermentation product prepared by the above method, which is very excellent in stability and safety and has excellent efficacy of anti-aging, anticancer, anti-inflammatory, immunity and the like.
본 발명이 해결하고자 하는 세 번째 과제는, 상기 발효물을 함유하는 약학 조성물을 제공하는 것이다.The third object of the present invention is to provide a pharmaceutical composition containing the fermented product.
본 발명이 해결하고자 하는 네 번째 과제는, 상기 발효물을 함유하는 화장품 조성물을 제공하는 것이다.The fourth problem to be solved by the present invention is to provide a cosmetic composition containing the fermented product.
본 발명이 해결하고자 하는 다섯 번째 과제는, 상기 발효물을 함유하는 식품 조성물을 제공하는 것이다.The fifth problem to be solved by the present invention is to provide a food composition containing the fermented product.
본 발명은 상기 첫 번째 과제를 달성하기 위해서,In order to achieve the first object of the present invention,
누룩을 이용한 당화 단계;Saccharification step using yeast;
유산균 배양을 통한 발효 단계; 및Fermentation step through lactic acid bacteria culture; And
상기 배양 결과물로부터 상등액을 수득하는 단계Obtaining a supernatant from the culture result
를 포함하는 천연 식물소재 및 한약재의 발효방법을 제공한다.It provides a natural plant material and fermentation method of the herbal medicine.
본 발명의 바람직한 일 실시예에 따르면, 상기 당화 단계는 천연 식물소재 및 한약재를 분쇄하는 단계, 누룩을 첨가하는 단계, 및 침지시키는 단계를 포함할 수 있다.According to a preferred embodiment of the present invention, the saccharification step may include the step of pulverizing natural plant material and herbal medicine, adding the yeast, and immersing.
본 발명의 바람직한 다른 실시예에 따르면, 상기 분쇄 단계의 분쇄물은 10㎛ 내지 1mm의 평균 입경을 가질 수 있다.According to another preferred embodiment of the present invention, the pulverized product of the grinding step may have an average particle diameter of 10㎛ to 1mm.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 천연 식물소재 및 한약재는 생강, 갈근, 감초, 녹차, 다시마, 당귀, 맥문동, 복분자, 산수유, 상백피, 오미자, 은행잎, 자초, 천문동, 치자, 캐모마일, 표고버섯, 감잎, 강낭콩, 계피, 고삼, 금은화, 도토리, 목단피, 포공영, 상황버섯, 석류, 송이버섯, 승마, 약쑥, 영지버섯, 오배자, 우엉, 율피, 황금, 황련, 황백, 괴화, 길경, 대나무, 도인, 옥죽, 백작약, 백지, 복령, 비파옆, 시호, 알로에, 익모초, 차전초, 창이자, 천궁, 천문동, 토사자, 하수오, 행인, 현미, 홍화, 감국, 결명자, 귀리, 녹두, 대추, 더덕, 단호박, 도인, 마치현, 모과, 목단피, 백리향, 산다화, 어성초, 연자육, 고본, 곽향, 대황, 방품, 백급, 백부자, 백지, 사상자, 가시오갈피, 감귤, 도인, 두충, 인삼, 홍삼, 천화분, 토마토, 파파야, 해송자, 행인, 겨우살이, 귀리, 녹용, 동충하초, 포도씨, 백강잠, 아가리쿠스버섯, 차가버섯, 연자육, 강황, 고추, 마늘, 구기자, 구아바, 구절초, 금송, 노근, 느릅나무, 두릅, 두충, 들깨, 루이보스, 마, 마황, 매실, 매화, 백급, 백리향, 병풀, 보골지, 보라지, 복분자, 비수리, 비자, 비파엽, 빈랑자, 산뽕나무, 산수유, 산초, 신선초, 아세로라, 아카시아, 약쑥, 올리 브잎, 와송, 우슬, 원지, 육두수, 은행잎, 자근, 자소엽, 죽순, 지구자, 지모, 지실, 지황, 차전초, 창이자, 창포, 천화분, 캐비어, 클로렐라, 스피루리나, 토사자, 파슬리, 포공영, 해송자, 행인, 함초, 호두, 회향 또는 그 혼합물일 수 있다.According to another preferred embodiment of the present invention, the natural plant material and herbal medicine is ginger, brown root, licorice, green tea, kelp, Angelica, Magmundong, Bokbunja, Cornus, Sangbaekpi, Schisandra chinensis, Ginkgo biloba, Licorice, Astronomical dong, Gardenia, Chamomile, Shiitake mushroom, persimmon leaf, kidney bean, cinnamon, red ginseng, gold and silver acorn, acorn, bark, pogongyoung, situation mushroom, pomegranate, matsutake, horse riding, wormwood, ganoderma lucidum, gall bladder, burdock, yulpi, golden, rhubarb, yellow white, chrysanthemum, gilkyung, Bamboo, cactus, jade juk, baekryeok, white paper, fueryeong, loquat, shiho, aloe, motherwort, chajeoncho, changza, cheongung, astronomical dong, earth and sand, sesao, passerby, brown rice, safflower, gamgu, deficiency, oats, mung bean, jujube, deodeok , Sweet pumpkin, cabbage, machi, quince, black bark, thyme, sanda flower, eoseongcho, lotus root, hard bones, gwahyang, rhubarb, article, white weight, baekbuja, white paper, casualty, ginseng, red citrus fruit, cabbage, cabbage, ginseng, red ginseng, cheonhwabun, Tomatoes, papayas, mutters, almonds, bran Flesh, Oat, Deer Antler, Cordyceps Sinensis, Grape Seed, White Nymph, Agaricus Mushroom, Chaga Mushroom, Lotus Root, Turmeric, Red Pepper, Garlic, Wolfberry, Guava, Gujeolcho, Golden Pine, Root, Elm, Arbor, Tortilla, Perilla, Rooibos, Hemp, Ephedra , Plum, plum, white, thyme, centella, golgoji, borage, bokbunja, non-recovery, visa, loquat, betel nut, mountain mulberry, cornus, sancho, fresh vinegar, acerola, acacia, wormwood, olive leaf, wasong, dew Garden, nutmeg, ginkgo biloba, root, purple leaf, bamboo shoot, earth, jimo, jisil, jihwang, chajeoncho, changja, irises, irises, caviar, chlorella, spirulina, earthenware, parsley, pogongyoung, mutter, pedestrian, hamcho, walnut , Fennel or mixtures thereof.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 누룩의 첨가량은 상기 분쇄물 100 중량부에 대해서 1 내지 10 중량부일 수 있다.According to another preferred embodiment of the present invention, the amount of the yeast added may be 1 to 10 parts by weight based on 100 parts by weight of the pulverized product.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 누룩의 첨가량은 상기 분쇄물 100 중량부에 대해서 2 내지 3 중량부일 수 있다.According to another preferred embodiment of the present invention, the amount of the yeast added may be 2 to 3 parts by weight based on 100 parts by weight of the pulverized product.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 침지 단계는 20 내지 40℃의 온도에서 18 내지 30시간 동안 수행될 수 있다.According to another preferred embodiment of the present invention, the immersion step may be performed for 18 to 30 hours at a temperature of 20 to 40 ℃.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 침지 단계 이후의 결과물에 대해서 살균하는 단계를 더 포함할 수 있다.According to another preferred embodiment of the present invention, the method may further include sterilizing the resultant after the immersion step.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 누룩을 제조하는데 사용된 균주는 거미줄곰팡이 (rhyzopus nigricans), 누룩곰팡이 (Aspergillus oryzae) 또는 그 혼합 균주일 수 있다.According to another preferred embodiment of the present invention, the strain used to prepare the yeast is spider web fungus ( rhyzopus nigricans ), yeast fungus ( Aspergillus oryzae ) or a mixed strain thereof.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 유산균은 락토바실러스 사케이 (Lactobacillus sakei B2-16), 락토바실러스 브레비스 (Lactobacillus brevis), 락토바실러스 플렌타럼 (Lactobacillus plantarum P23), 락토코커스 락티스 (Lactococcus lactis A164), 바실러스 코아귤런스 (Bacillus coagulance) 또는 그 혼합 균주일 수 있다.According to another preferred embodiment of the present invention, the lactic acid bacteria is Lactobacillus Sakei ( Lactobacillus sakei B2-16), Lactobacillus brevis (Lactobacillus brevis), Lactobacillus flange tareom (Lactobacillus plantarum P23 ), Lactococcus lactis A164 ), Bacillus coagulum coagulance ) or a mixed strain thereof.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 유산균 배양을 통한 발 효 단계 시에는 효모균인 사카로마이세스 세레비지에 (Saccharomyces cerevisiae) 균주를 더 첨가할 수 있다.According to another preferred embodiment of the present invention, during the fermentation step through the lactic acid bacteria culture Saccharomyces yeast Saccharomyces ( Saccharomyces cerevisiae ) strain may be added further.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 유산균 또는 효모균의 접종량은 접종 초기 균수가 105 내지 108 cfu/g 또는 105 내지 108 cfu/㎖일 수 있다.According to another preferred embodiment of the present invention, the inoculation amount of the lactic acid bacteria or yeast may be 10 5 to 10 8 cfu / g or 10 5 to 10 8 cfu / ㎖ initial inoculation.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 유산균은 김치 또는 된장으로부터 분리된 균주이며, 상기 효모균은 청주 제조시에 사용되는 균주일 수 있다.According to another preferred embodiment of the present invention, the lactic acid bacteria is a strain isolated from kimchi or miso, the yeast may be a strain used in the production of sake.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 유산균 배양을 통한 발효 단계는 15 내지 40℃의 온도에서 18 내지 120 시간 동안 수행될 수 있다.According to another preferred embodiment of the present invention, the fermentation step through the lactic acid bacteria culture may be performed for 18 to 120 hours at a temperature of 15 to 40 ℃.
본 발명의 바람직한 또 다른 실시예에 따르면, 상기 상등액 수득 단계는 여과 또는 원심분리에 의해서 수행될 수 있다.According to another preferred embodiment of the present invention, the supernatant obtaining step may be performed by filtration or centrifugation.
본 발명은 상기 두 번째 과제를 달성하기 위해서,In order to achieve the second object of the present invention,
상기 천연 식물소재 및 한약재의 발효방법에 의해서 제조된 발효물을 제공한다.It provides a fermented product prepared by the fermentation method of the natural plant material and herbal medicine.
본 발명은 상기 세 번째 과제를 달성하기 위해서,The present invention to achieve the third object,
상기 발효물을 함유하는 약학 조성물을 제공한다.It provides a pharmaceutical composition containing the fermented product.
본 발명은 상기 네 번째 과제를 달성하기 위해서,In order to achieve the fourth object of the present invention,
상기 발효물을 함유하는 화장품 조성물을 제공한다.It provides a cosmetic composition containing the fermented product.
또한, 본 발명은 상기 다섯 번째 과제를 달성하기 위해서,In addition, the present invention to achieve the fifth object,
상기 발효물을 함유하는 식품 조성물을 제공한다.It provides a food composition containing the fermented product.
이하, 본 발명을 더욱 상세하게 설명하기로 한다.Hereinafter, the present invention will be described in more detail.
본 발명은 천연 식물소재 또는 한약재의 다양한 생리활성을 더욱 안정적이고, 독성이 적으며, 효과적으로 이용하기 위해서, 이러한 천연 식물소재 또는 한약재에 대한 생물학적 전환 방법으로서 발효과정을 이용하고자 하였으며, 누룩을 이용한 당화 단계 및 유산균에 의한 발효 단계를 효과적으로 연계시킴으로써, 별도의 탄소원 첨가 없이도 유산균 발효 효율을 극대화하고자 하였다.The present invention intends to use the fermentation process as a biological conversion method for such natural plant material or herbal medicine, in order to use more physiological activity of natural plant material or herbal medicine more stable, less toxic, and effective, and saccharification using yeast By effectively linking the step and the fermentation step by lactic acid bacteria, it was intended to maximize the lactic acid bacteria fermentation efficiency without the addition of a separate carbon source.
천연 식물소재 또는 한약재에 대한 생물학적 전환 방법으로서, 가장 경제적이면서도 그 안전성이 검증된 방법은 발효방법이다. 그러나, 미생물을 이용한 발효과정을 원활하게 수행하기 위해서는 해당 미생물이 잘 성장할 수 있는 조건을 마련해 주어야 하지만, 대부분의 천연 식물소재 및 한약재는 이러한 환경을 제공해 주기가 어렵다. 이는 미생물이 잘 성장하기 위해서는 탄소원으로서 이용하기 쉬운 형태의 포도당이 존재하여야 하지만, 대부분의 천연 식물소재 및 한약재에는 이러한 형태의 탄소원이 많이 존재하지 않기 때문이다. 따라서, 우수한 생리활성을 갖는 것으로 알려진 여러 천연 식물소재 또는 한약재에 발효 미생물을 배양해서는 원하는 생물학적 전환을 유도해 내기가 어렵다.As a biological conversion method for natural plant material or herbal medicine, the most economical and proven method of safety is fermentation method. However, in order to perform the fermentation process using microorganisms smoothly, it is necessary to provide conditions for growth of the microorganisms, but most natural plant materials and herbal medicines cannot provide such an environment. This is because glucose is easy to use as a carbon source in order to grow microorganisms well, but most natural plant materials and herbal medicines do not have many carbon sources of this type. Therefore, culturing fermented microorganisms on various natural plant materials or herbal medicines known to have good physiological activity makes it difficult to induce the desired biological conversion.
본 발명에서는 이러한 문제점을 해결하기 위해서 누룩 (또는 곡자)과 유산균을 사용하였다. 일반적으로 누룩이라 하면, 술을 만드는 효소를 갖는 곰팡이를 쌀과 같은 곡류에 번식시킨 것을 의미하며, 누룩의 주된 역할은 곡류에 존재하는 전 분질 원료를 당화시키는 것이다. 따라서, 이러한 누룩의 당화 작용에 의한 결과물을 유산균의 성장 영양분으로 이용함으로써 효과적이면서도 편리한 방법으로 천연 식물소재 및 한약재에 대한 발효를 수행할 수 있게 되는 것이다.In the present invention, Nuruk (or grain) and lactic acid bacteria were used to solve this problem. In general, yeast means that molds containing alcohol-producing enzymes are propagated in grains such as rice. The main role of yeast is to saccharify starch raw materials present in grains. Therefore, by using the result of the saccharifying action of yeast as a growth nutrient of lactic acid bacteria, it is possible to perform fermentation on natural plant material and herbal medicine in an effective and convenient way.
구체적으로, 본 발명에 따른 천연 식물소재 및 한약재의 발효방법은, 누룩을 이용한 당화 단계; 유산균 배양을 통한 발효 단계; 및 상기 배양 결과물로부터 상등액을 수득하는 단계를 포함하며, 특히 상기 당화 단계는 천연 식물소재 및 한약재를 분쇄하는 단계, 누룩을 첨가하는 단계, 및 침지시키는 단계를 포함할 수 있다.Specifically, the fermentation method of natural plant material and herbal medicine according to the present invention, the saccharification step using Nuruk; Fermentation step through lactic acid bacteria culture; And obtaining a supernatant from the culture result, in particular, the saccharification step may include pulverizing natural plant material and herbal medicine, adding yeast, and immersing.
도 1에는 본 발명에 따른 천연 식물소재 및 한약재의 발효방법에 대한 공정도를 개략적으로 도시하였으며, 이하 도 1을 참조하여 본 발명을 더욱 상세하게 설명하기로 한다.1 schematically shows a process diagram for a fermentation method of natural plant material and herbal medicine according to the present invention, hereinafter, the present invention will be described in more detail with reference to FIG.
먼저, 분쇄 단계는 누룩에 의한 당화 과정이 더욱 용이하게 진행될 수 있도록 하기 위한 것으로서, 분쇄 단계로부터 얻어진 분쇄물은 10㎛ 내지 1mm의 평균 입경을 가질 수 있다.First, the grinding step is to facilitate the saccharification process by the yeast, the grinding material obtained from the grinding step may have an average particle diameter of 10㎛ to 1mm.
본 발명이 적용될 수 있는 천연 식물소재 및 한약재로는, 인체에 유용한 다양한 생리활성을 갖는 여러 가지 물질들을 예로 들 수 있으며, 이에 제한되는 것은 아니지만, 생강, 갈근, 감초, 녹차, 다시마, 당귀, 맥문동, 복분자, 산수유, 상백피, 오미자, 은행잎, 자초, 천문동, 치자, 캐모마일, 표고버섯, 감잎, 강낭콩, 계피, 고삼, 금은화, 도토리, 목단피, 포공영, 상황버섯, 석류, 송이버섯, 승마, 약쑥, 영지버섯, 오배자, 우엉, 율피, 황금, 황련, 황백, 괴화, 길경, 대나무, 도인, 옥죽, 백작약, 백지, 복령, 비파옆, 시호, 알로에, 익모초, 차전초, 창이자, 천궁, 천문동, 토사자, 하수오, 행인, 현미, 홍화, 감국, 결명자, 귀리, 녹두, 대추, 더덕, 단호박, 도인, 마치현, 모과, 목단피, 백리향, 산다화, 어성초, 연자육, 고본, 곽향, 대황, 방품, 백급, 백부자, 백지, 사상자, 가시오갈피, 감귤, 도인, 두충, 인삼, 홍삼, 천화분, 토마토, 파파야, 해송자, 행인, 겨우살이, 귀리, 녹용, 동충하초, 포도씨, 백강잠, 아가리쿠스버섯, 차가버섯, 연자육, 강황, 고추, 마늘, 구기자, 구아바, 구절초, 금송, 노근, 느릅나무, 두릅, 두충, 들깨, 루이보스, 마, 마황, 매실, 매화, 백급, 백리향, 병풀, 보골지, 보라지, 복분자, 비수리, 비자, 비파엽, 빈랑자, 산뽕나무, 산수유, 산초, 신선초, 아세로라, 아카시아, 약쑥, 올리브잎, 와송, 우슬, 원지, 육두수, 은행잎, 자근, 자소엽, 죽순, 지구자, 지모, 지실, 지황, 차전초, 창이자, 창포, 천화분, 캐비어, 클로렐라, 스피루리나, 토사자, 파슬리, 포공영, 해송자, 행인, 함초, 호두, 회향 또는 그 혼합물을 예로 들 수 있다.Natural plant materials and herbal medicines to which the present invention can be applied include, but are not limited to, various substances having various physiological activities useful for the human body, but are not limited thereto. Ginger, brown root, licorice, green tea, kelp, Angelica, and Macmundong , Bokbunja, Cornus, White peach, Schisandra chinensis, Ginkgo biloba, Korean herb, Astronomical dong, Gardenia, Chamomile, Shiitake, Persimmon leaf, Kidney bean, Cinnamon, Red ginseng, Gold silver coin, Acorn, Peony, Pogongyoung, Situation mushroom, Pomegranate, Pine mushroom, Horse riding, Mugwort, Ganoderma lucidum, gall bladder, burdock, yulpi, golden, yellow lotus, yellow white, chrysanthemum, gilgyeong, bamboo, cabbage, jade porridge, count, white paper, fueryeong, loquat, siho, aloe, motherwort, chajeoncho, changja, cheongung, cheonmundong, tosa, Shou, pedestrian, brown rice, safflower, gums, glitches, oats, mung beans, jujube, deodeok, sweet pumpkin, cabbage, machi, quince, bark skin, thyme, sanda flower, eoseongcho, lotus root, kobon, kwak hyang, rhubarb, article, salary, baekbuja, Blank paper , Prickly pear, tangerine, cabbage, tofu, ginseng, red ginseng, natural flower, tomato, papaya, pine rapeseed, almond, mistletoe, oat, antler, cordyceps, grape seed, white goose, agaricus mushroom, chaga, lotus root, turmeric, red pepper, garlic, Gugija, guava, gujeolcho, calendula, root root, elm, arthropod, tofu, perilla, rooibos, hemp, ephedra, plum, plum, white, thyme, centella, golboji, borage, bokbunja, non-repair, visa, loquat leaf, betel nut Purple, mountain mulberry, Cornus, Sancho, Sinseoncho, acerola, acacia, wormwood, olive leaf, hawthorn, dew, grass, nutmeg, ginkgo biloba, root, purple leaf, bamboo shoot, earthly, jimo, jisil, jihwang, chajeoncho, changja Examples include irises, nectars, caviar, chlorella, spirulina, earthenware, parsley, pogongyoung, sea stalks, almonds, seaweeds, walnuts, fennel or mixtures thereof.
한편, 누룩을 제조하기 위한 원료 곡물로는, 밀 또는 쌀에 밀가루를 입힌 것을 원부재료로 하고, 여기에 녹두, 찹쌀 또는 보리 등이 함께 사용되기도 한다. 또한, 효모원으로는 도꼬마리, 보릿짚, 벗 짚, 뽕나무, 쑥, 상주, 연꽃, 솔대 잎 여뀌의 어린 잎, 솔잎 등이 있다. 원료 곡물의 증자 여부는 볶은 것, 낀 것, 살짝 찐 것, 날 밀 등이 있으며, 원료의 입도는 12할부터 미분까지 가능하다. 주원료의 종류에는 뽕나무 잎, 쑥, 수유를 달인 즙, 복숭아씨 분말, 살구씨 분말, 참외 분말 등이 있다.On the other hand, as a raw grain for producing yeast, a wheat flour or a wheat flour is used as a raw material, and mung bean, glutinous rice or barley may be used together. In addition, yeasts include dokmari, barley straw, bark straw, mulberry, wormwood, resident, lotus, young leaves of pine needles, pine needles and the like. Raw grains can be cooked or roasted, steamed, steamed, or raw wheat. The grain size can range from 12% to fine powder. Types of main ingredients include mulberry leaves, mugwort, lactating juice, peach seed powder, apricot seed powder and melon powder.
당화 과정을 위해서 첨가되는 누룩의 첨가량은 상기 분쇄물 100 중량부를 기준으로 1 내지 10 중량부, 바람직하게는 2 내지 3 중량부일 수 있다. 누룩의 첨가량이 10 중량부를 초과하는 경우에는 곰팡이 냄새 발생 등의 염려가 있고, 1 중량부 미만인 경우에는 당화가 충분히 일어나지 않아 이후의 유산균 발효효율이 떨어지는 문제점이 있어서 바람직하지 않다.The amount of yeast added for the saccharification process may be 1 to 10 parts by weight, preferably 2 to 3 parts by weight, based on 100 parts by weight of the pulverized product. If the amount of yeast is more than 10 parts by weight, there is a concern such as the occurrence of a mold odor, if less than 1 part by weight does not cause saccharification enough, there is a problem that the subsequent lactic acid bacteria fermentation efficiency is not preferable.
누룩 곰팡이는 일반적으로 그 색상에 따라 황국균, 흑국균 또는 홍국균 등으로 분류되며, 크게 떡 누룩 (병국) 또는 흩임 누룩 (신국)으로 분류되기도 한다. 병국에 서식하는 곰팡이로는 내부까지 기어드는 발효형으로서, 거미줄곰팡이 (rhyzopus nigricans), 효모, 털곰팡이 등이 있고, 신국에 서식하는 곰팡이로는 표면에만 번식하는 호흡형으로서, 누룩곰팡이 (Aspergillus oryzae) 등이 있다.The yeast fungus is generally classified into yellow yeast, black yeast or red yeast fungus according to its color, and is also classified into rice yeast (sick soup) or scattered yeast (new soup). A fungus that inhabits the byeongguk is geared as a fermented type from the inside, there is a cobweb mold (rhyzopus nigricans), yeast, mold and hair, a fungus that lives in the new national is a breathing that breed only on the surface, koji mold (Aspergillus oryzae ).
본 발명에서 누룩 제조에는, 상기 떡 누룩 또는 흩임 누룩 등이 고루 사용될 수 있지만, 특히 거미줄곰팡이 (rhyzopus nigricans), 누룩곰팡이 (Aspergillus oryzae) 또는 그 혼합 균주가 사용되는 것이 바람직하다.In manufacturing yeast in the present invention, the rice cake yeast or scattered yeast may be used evenly, in particular, spider web mold ( rhyzopus nigricans ), yeast fungi ( Aspergillus oryzae ) or mixed strains thereof are preferably used.
누룩 첨가 후의 침지 단계는 20 내지 40℃의 온도에서 18 내지 30시간 동안 수행되는 것이 바람직하며, 이는 이는 누룩 곰팡이 유래 효소의 활성을 나타내는 최적의 온도이기 때문이다. 이 온도에서 누룩 곰팡이에 의해 생성되는 유기산은 코지산, 글루콘산등이 있고, 유발되는 효소는 아밀라제, 말타제, 인베르타제, 셀룰라제, 이눌리나제 및 단백질 분해효소등이 있다. The soaking step after the addition of the yeast is preferably carried out at a temperature of 20 to 40 ° C. for 18 to 30 hours, since this is the optimum temperature that indicates the activity of the yeast fungus derived enzyme. Organic acids produced by the yeast fungus at this temperature include kojic acid and gluconic acid, and the enzymes induced include amylase, maltase, invertase, cellulase, inulinase and protease.
또한, 상기 침지 단계 이후에는 후속 유산균 배양을 통한 발효 단계로부터 얻어진 발효물의 순도를 높이기 위해서, 살균 단계가 더 수행될 수도 있으며, 이러 한 살균 단계는 예를 들어 121℃, 1.5 기압의 조건에서 20분 내지 40분 동안 열처리함으로써 수행될 수 있다.In addition, after the immersion step, in order to increase the purity of the fermentation product obtained from the fermentation step through the subsequent lactic acid bacteria culture, sterilization step may be further performed, such sterilization step is for example 20 minutes at 121 ℃, 1.5 atmosphere By heat treatment for from 40 minutes.
다음으로, 상기와 같이 당화 단계가 완료되면, 유산균 배양을 통한 발효 단계가 수행된다.Next, when the saccharification step is completed as described above, the fermentation step through the lactic acid bacteria culture is performed.
본 발명에서 사용가능한 유산균으로는, 이에 제한되는 것은 아니지만, 락토바실러스 사케이 (Lactobacillus sakei B2-16), 락토바실러스 브레비스 (Lactobacillus brevis ), 락토바실러스 플렌타럼 (Lactobacillus plantarum P23), 락토코커스 락티스 (Lactococcus lactis A164), 바실러스 코아귤런스 (Bacillus coagulance) 또는 그 혼합 균주를 예로 들 수 있으며, 여기에는 효모균인 사카로마이세스 세레비지에 (Saccharomyces cerevisiae) 균주를 더 첨가해 줄 수도 있다.Lactic acid bacteria that can be used in the present invention, but is not limited thereto, Lactobacillus sakei B2-16), Lactobacillus brevis (Lactobacillus brevis), Lactobacillus flange tareom (Lactobacillus plantarum P23 ), Lactococcus lactis A164 ), For example, Bacillus coagulance or a mixed strain thereof, including the yeast Saccharomyces ( Saccharomyces) cerevisiae ) strain may be added.
상기 유산균 또는 효모균의 접종량은 접종 초기 균수가 105 내지 108 cfu/g 또는 105 내지 108 cfu/㎖인 것이 바람직한데, 접종 초기 균수가 105 cfu/g 또는 105 cfu/㎖ 미만인 경우에는 발효시간이 길어지는 문제점이 있고, 108 cfu/g 또는 108 cfu/㎖를 초과하는 때에는 효과의 증가가 크지 않음에도 접종량이 과도한 문제가 있다.The inoculation amount of the lactic acid bacteria or yeast is preferably 10 5 to 10 8 cfu / g or 10 5 to 10 8 cfu / ㎖ initial inoculation, when the initial inoculation bacteria is less than 10 5 cfu / g or 10 5 cfu / ㎖ There is a problem in that the fermentation time is long, and when the amount exceeds 10 8 cfu / g or 10 8 cfu / ㎖ there is a problem of excessive inoculation amount even if the increase of the effect is not large.
상기 유산균들은 한국 전통식품인 김치 또는 된장 등으로부터 용이하게 분리 가능하며, 상기 효모균 역시 청주 제조시에 사용되는 균주를 사용할 수 있다.The lactic acid bacteria can be easily separated from kimchi or doenjang, which is a traditional Korean food, and the yeast may also use strains used in the production of sake.
한편, 유산균 배양을 통한 발효 단계는, 최적의 유산균 발효 조건을 고려할 때에, 15 내지 40℃의 온도에서 18 내지 120 시간 동안 수행될 수 있다.On the other hand, the fermentation step through the lactic acid bacteria culture, when considering the optimum lactic acid bacteria fermentation conditions, may be performed for 18 to 120 hours at a temperature of 15 to 40 ℃.
마지막으로, 유산균 배양을 통한 발효 결과물로부터 상등액을 수득하는 단계가 수행되며, 이는 여과 또는 원심분리 등의 다양한 방법에 의해서 수행될 수 있다.Finally, a step of obtaining a supernatant from the fermentation product through the lactic acid bacteria culture is performed, which may be performed by various methods such as filtration or centrifugation.
본 발명의 두 번째 과제는 상기 천연 식물소재 및 한약재의 발효방법에 의해서 제조된 발효물을 제공하는 것이며, 본 발명에 따른 발효물은 하기 실시예에서 서술하는 바와 같이, 콜라겐 합성 촉진 효과, 피부 미백 효과, 항산화 효과 등이 우수하여, 피부 노화 방지 및 개선, 피부 턴오버 보조, 피부 손상 방지 및 개선, 항산화, 항염증 등의 효과를 갖는 다양한 약학 조성물, 화장품 조성물 또는 식품 조성물 등에 유효성분으로 함유될 수 있다.The second object of the present invention is to provide a fermented product prepared by the fermentation method of the natural plant material and herbal medicine, the fermentation product according to the present invention, as described in the following examples, collagen synthesis promoting effect, skin whitening Excellent effect, antioxidant effect, etc., to be included as an active ingredient in various pharmaceutical compositions, cosmetic compositions or food compositions having the effects of preventing and improving skin aging, assisting skin turnover, preventing and improving skin damage, antioxidant, anti-inflammatory, etc. Can be.
따라서, 본 발명의 세 번째, 네 번째 및 다섯 번째 과제는 상기 발효물을 함유하는 약학 조성물, 화장품 조성물 및 식품 조성물을 제공하는 것이며, 본 발명에 따른 조성물들은, 본 발명이 목적으로 하는 주 효과를 손상시키지 않는 범위 내에서 주 효과에 상승 효과를 줄 수 있는 다른 성분 등을 함유할 수도 있으며, 예를 들어 물성 개선을 위하여 향료, 색소, 살균제, 산화방지제, 방부제, 보습제, 점증제, 무기염류, 유화제, 합성 고분자 물질 등의 첨가제를 더 포함할 수도 있을 뿐만 아니라, 수용성 비타민, 유용성 비타민, 고분자 펩티드, 고분자 다당 및 해초 엑기스 등의 보조 성분을 더 포함할 수도 있다. 상기 성분들은 제형 또는 사용 목적에 따라서 당업자가 어려움 없이 적의 선정하여 배합할 수 있으며, 그 첨가량은 본 발명의 목적 및 효과를 손상시키지 않는 범위 내에서 선택될 수 있지만, 조성물 총중량에 대하여 0.01~5 중량%, 바람직하게는 0.01∼3 중량%일 수 있다.Accordingly, the third, fourth and fifth task of the present invention is to provide a pharmaceutical composition, a cosmetic composition and a food composition containing the fermentation product, and the compositions according to the present invention provide the main effects aimed at by the present invention. It may contain other ingredients that can give a synergistic effect to the main effect within the range of not being damaged, and for example, fragrances, pigments, fungicides, antioxidants, preservatives, humectants, thickeners, inorganic salts, In addition to an additive such as an emulsifier and a synthetic polymer, it may further include auxiliary ingredients such as water-soluble vitamins, oil-soluble vitamins, polymer peptides, polymer polysaccharides, and seaweed extracts. The components may be appropriately selected and blended by those skilled in the art according to the formulation or purpose of use, and the amount may be selected within a range that does not impair the object and effect of the present invention, but 0.01 to 5 weight based on the total weight of the composition. %, Preferably 0.01 to 3% by weight.
또한, 본 발명에 따른 조성물의 제형 역시 용액, 유화물, 점성형 혼합물, 타블렛, 분말 등의 다양한 형태일 수 있으며, 이는 단순 음용, 주사 투여, 스프레이 방식 또는 스퀴즈 방식 등의 다양한 방법으로 투여될 수 있다.In addition, the formulation of the composition according to the present invention may also be in various forms such as solution, emulsion, viscous mixture, tablet, powder, etc., which may be administered by various methods such as simple drinking, injection, spray or squeeze method. .
본 발명에 따르면, 일상 생활에서 용이하게 섭취가능한 천연 식물성 소재나 생리활성이 강하여 한의학에서 사용되는 한약재를 누룩 및 유산균을 이용하여 발효시킴으로써 별도의 탄소원 첨가 없이도 유산균 발효 효율을 높일 수 있으며, 제조된 발효물은 안정성 및 안전성이 매우 뛰어나고 우수한 항노화, 항암, 항염, 면역 개선 등의 효능을 갖기 때문에 약학 조성물, 화장품 조성물 및 식품 조성물 등에 유용하게 포함될 수 있는, 천연 식물소재 및 한약재의 발효방법, 상기 방법에 의해서 제조된 발효물 및 이를 함유하는 약학 조성물, 화장품 조성물 및 식품 조성물을 제공할 수 있다.According to the present invention, it is possible to increase the fermentation efficiency of lactic acid bacteria without the addition of a carbon source by fermenting a natural plant material or a physiological activity that is easily ingested in daily life and using medicinal herbs used in oriental medicine using Nuruk and lactic acid bacteria. Since water is very stable and safe and has excellent efficacy of anti-aging, anticancer, anti-inflammatory, and immunity, it may be usefully used in pharmaceutical compositions, cosmetic compositions and food compositions, fermentation methods of natural plant materials and herbal medicines, the method It can be provided a fermentation product prepared by and a pharmaceutical composition, a cosmetic composition and a food composition containing the same.
이하, 실시예 및 평가예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 그러나, 이들 실시예 및 평가예는 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예 및 평가예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가진 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples and Evaluation Examples. However, these examples and evaluation examples are intended to explain the present invention in more detail, and the scope of the present invention is not limited by these examples and evaluation examples according to the gist of the present invention is common knowledge in the art. It will be self-evident for those who have.
실시예Example 1. 본 발명에 따른 천연 식물소재 또는 한약재 1. Natural plant material or herbal medicine according to the present invention 발효물의Fermented product 제조 Produce
갈근 100g을 30℃ 이하의 냉수로 약 30분 정도 세척하고 분쇄기로 분쇄한 다 음, 분쇄물이 고형분 기준으로 3 중량%가 되도록 물을 첨가한 후, 누룩을 첨가하고 상온에서 24시간 동안 침지시켰다. 누룩은 밀끼울과 물을 각 5:1의 비율로 섞어 잘 버무린 후 배양한 거미줄곰팡이 (rhyzopus nigricans), 누룩곰팡이 (Aspergillus oryzae) 또는 그 혼합 균주를 접종하고 25℃에서 30℃의 범위에서 3∼5일간 배양하여 사용하였다. 이때, 누룩의 첨가량은 분쇄물 100 중량부에 대해서 2.5 중량부가 되도록 하였다. 침지 후, 침지 결과물을 121℃에서 30분간 열처리하여 살균하였다. 이어서, 미리 배양된 유산균 Lactobacillus plantarum P23을 107 cfu/㎖의 농도가 되도록 첨가한 다음, 37 ℃에서 3∼5일간 배양하고, 연속식 원심분리기를 이용하여 상등액을 채취하였다.100 g of brown root was washed with cold water of 30 ° C. or less for about 30 minutes, pulverized with a pulverizer, and then water was added so that the pulverized powder was 3% by weight based on solids. . Nuruk is mixed with wheat grass and water at a ratio of 5: 1 and mixed well, and then inoculated with cultured spider fungus ( rhyzopus nigricans ), yeast fungus ( Aspergillus oryzae ) or a mixed strain thereof, and inoculated with 3∼3 at 25 ° C to 30 ° C. The culture was used for 5 days. At this time, the amount of Nuruk added was 2.5 parts by weight based on 100 parts by weight of the pulverized product. After immersion, the immersion product was sterilized by heat treatment at 121 ° C. for 30 minutes. Subsequently, Lactobacillus , previously cultured plantarum P23 was added to a concentration of 10 7 cfu / ml, then incubated at 37 ° C. for 3-5 days, and the supernatant was collected using a continuous centrifuge.
실시예Example 2 내지 32. 본 발명에 따른 천연 식물소재 또는 한약재 2 to 32. Natural plant material or herbal medicine according to the present invention 발효물의Fermented product 제조 Produce
갈근 대신에, 각각 감초(실시예 2), 녹차(실시예 3), 다시마(실시예 4), 당귀(실시예 5), 맥문동(실시예 6), 복분자(실시예 7), 산수유(실시예 8), 생강(실시예 9), 상백피(실시예 10), 오미자(실시예 11), 은행잎(실시예 12), 자초(실시예 13), 천문동(실시예 14), 치자(실시예 15), 캐모마일(실시예 16), 표고버섯(실시예 17), 상황버섯(실시예 18), 홍삼(실시예 19), 석류(실시예 20), 약쑥(실시예 21), 하수오(실시예 22), 사상자(실시예 23), 행인(실시예 24), 알로에(실시예 25), 더덕(실시예 26), 마치현(실시예 27), 어성초(실시예 28), 천궁(실시예 29), 포공영 (실시예 30), 가시오가피(실시예 31), 두충(실시예 32)을 사용하였다는 점을 제외하고는, 상기 실시예 1과 동일한 방법에 의해서 실시예 2 내지 32에 따른 발효물들을 제조하였다.Instead of brown root, licorice (Example 2), green tea (Example 3), kelp (Example 4), Angelica (Example 5), Macmundong (Example 6), Bokbunja (Example 7), Cornus milk (Example) Example 8) Ginger (Example 9), Morus bark (Example 10), Schisandra chinensis (Example 11), Ginkgo biloba (Example 12), Licorice (Example 13), Astronomical dong (Example 14), Gardenia (Example) 15), chamomile (Example 16), shiitake mushroom (Example 17), situation mushroom (Example 18), red ginseng (Example 19), pomegranate (Example 20), wormwood (Example 21), sewage Example 22) Casualty (Example 23), Pedestrian (Example 24), Aloe (Example 25), Muduck (Example 26), March (Example 27), Eochocho (Example 28), Archery (Example) 29), fermentation according to Examples 2 to 32 by the same method as in Example 1, except that poongyoung (Example 30), thorn stem (Example 31), and worms (Example 32) were used. Waters were prepared.
비교예Comparative example 1 내지 32. 종래기술에 따른 천연 식물소재 또는 한약재 1 to 32. Natural plant material or herbal medicine according to the prior art 발효물의Fermented product 제조 Produce
누룩을 이용한 당화단계를 수행하지 않고 직접 유산균 배양을 통한 발효단계를 수행하였다는 점을 제외하고는, 실시예 1과 동일한 방법으로 발효물을 수득하였다.A fermentation product was obtained in the same manner as in Example 1, except that the fermentation step was performed directly through lactic acid bacteria culture without performing the saccharification step using Nuruk.
평가예Evaluation example 1. 발효 효율 평가 1. Evaluation of fermentation efficiency
상기 실시예 1 내지 32와 비교예 1 내지 32에 따른 발효물의 발효 정도를 비교하기 위한 척도로서 pH를 사용하였다. 유산균의 경우 균체의 성장에 비례하여 pH가 감소하는 경향을 보이므로 pH가 떨어진 정도를 비교하여 발효효율을 나타내었으며 그 결과를 하기 표 1에 도시하였다. 표 1을 참조하면, 발효효율(pH 감소율%)이란 비교예와 비교할 때에 실시예에서 추가로 감소한 pH를 백분율로 나타낸 것이다. 예를 들어, 갈근에 대한 실시예 1의 경우, 비교예 1과 비교할 때에 pH가 15%정도 추가로 감소하였다. PH was used as a measure for comparing the fermentation degree of the fermentation products according to Examples 1 to 32 and Comparative Examples 1 to 32. In the case of lactic acid bacteria, the pH showed a tendency to decrease in proportion to the growth of the cells, and the fermentation efficiency was shown by comparing the degree of drop in pH. The results are shown in Table 1 below. Referring to Table 1, the fermentation efficiency (% reduction in pH) is a percentage of the pH which was further reduced in the examples when compared with the comparative example. For example, in the case of Example 1 for rooting, the pH was further reduced by 15% compared to Comparative Example 1.
평가예Evaluation example 2. 세포 독성 검사 2. Cytotoxicity Test
피부세포 (Fibroblast)를 96웰 플레이트에 접종한 후, 실시예 1 내지 32에 따른 발효물을 농도별로 첨가한 배지를 넣고 1 내지 2일간 배양하였다. 배지를 제거한 후, MTT 용액을 첨가하고 2∼3시간 반응시킨 후, MTT용액을 제거하고 DMSO를 첨가한 다음, 포마존 크리스탈을 혼합해 주었다. 흡광도를 측정하여 세포 사멸 정도(독성농도)를 비교하였으며, 실시예 1 내지 32에서 사용한 천연식물 또는 한약재의 추출물과 비교할 때에, 동일한 세포사멸을 나타내는데 첨가되는 발효물의 농도를 배수로 표현한 결과를 하기 표 1에 나타내었다. 예를 들어, 갈근에 대한 실시예 1의 경우 갈근 추출물 자체와 비교할 때에 동일한 세포사멸을 나타내는데 첨가되는 농도가 3배 정도로 나타났으므로 본 발명에 따른 발효물의 경우 세포 독성이 현저히 감소한 것을 알 수 있다.After inoculating the skin cells (Fibroblast) in 96-well plate, the medium to which the fermentation products according to Examples 1 to 32 were added for each concentration was incubated for 1 to 2 days. After the medium was removed, MTT solution was added and reacted for 2 to 3 hours. Then, the MTT solution was removed, DMSO was added, and the formazone crystal was mixed. Absorbance was measured to compare the degree of cell death (toxic concentration), and compared with the extract of the natural plant or herbal medicine used in Examples 1 to 32, the result of expressing the concentration of the fermentation product added to show the same cell death in multiples. Shown in For example, in the case of Example 1 for the root of the roots compared to the extract of the root of the root itself, the concentration added to show the same apoptosis can be seen that the cytotoxicity is significantly reduced in the case of the fermentation according to the present invention.
평가예Evaluation example 3. 3. 발효물의Fermented product 미백 효과 Whitening effect
하기의 3가지 방법에 의해서 실시예 1 내지 32에 따른 발효물의 미백효과를 평가하였으며, 그 결과를 하기 표 1에 나타내었다. 발효물의 미백효과는 하기의 멜라닌 종양세포에서의 멜라닌 합성저해효과 및 타이로시네이즈 발현억제효과를 종합하여 - (미백효과 없슴), + (약간의 미백효과를 보임), ++ (미백효과가 우수함), +++ (미백효과가 매우 우수함)으로 표시하였으며, 이중 미백효과가 가장 우수한 실시예 17에 대한 각각의 결과를 도 2 및 3에 도시하였다.The whitening effect of the fermented products according to Examples 1 to 32 was evaluated by the following three methods, the results are shown in Table 1 below. The whitening effect of the fermentation product is based on the melanin synthesis inhibitory effect and tyrosinase expression inhibition effect in melanin tumor cells as follows-(no whitening effect), + (shows a slight whitening effect), ++ (whitening effect Excellent), +++ (the whitening effect is very good), and the results of Example 17 for which the whitening effect is most excellent are shown in FIGS. 2 and 3.
1) 멜라닌 종양 세포에서의 멜라닌 합성 저해 효과Inhibitory Effects of Melanin Synthesis on Melanin Tumor Cells
실시예 1 내지 32에 따른 발효물들의 멜라닌 종양 세포에서 멜라닌 합성 저해 효과를 알아보기 위하여 하기와 같은 실험을 수행하였다.In order to determine the effect of inhibiting melanin synthesis in melanin tumor cells of the fermentations according to Examples 1 to 32 were carried out the following experiment.
먼저, 마우스 유래 악성 멜라닌 종양 세포주 B16F1 (KCLB 8007)를 페니실린 (100 IU/mL), 스트렙토마이신 (100 g/mL), 10% FBS (fetal bovine serum)를 함유하는 DMEM (Dulbecco's Modified Eagle's Medium) 배지에 넣고 37℃를 유지하며 5% 이산화탄소를 포함하는 배양기 내에서 배양하였다. 수득된 멜라닌 종양 세포를 24웰 플레이트 (well plate)에 1 × 104 세포/웰 (cells/well)에 접종 (seeding)하여 1일 배양하였다. 배양 후 배지를 제거한 다음, 멜라닌 합성을 유도시키기 위하여, alpha-MSH (melanocyte stimulating hormone; 멜라노사이트 자극 호르몬)을 비처리군을 제외하고 50 nM을 첨가하여 멜라닌 합성을 유도하였고, 동시에 상기 실시예 1 내지 32를 통해 얻어진 발효물을 각각 0.1%, 0.5%, 1% 및 코직산 (양성대조군) 800 μM를 가한 DMEM 배지를 첨가하여 3일간 배양하였다. 각 처리군에 의한 멜라닌 종양세포가 분비한 합성된 멜라닌 양을 육안으로 확인하고 그 변화를 디지털 카메라로 촬영하였으며, 각 처리군의 세포를 수거하여 10% DMSO (Dimethyl sulfoxide)와 1N NaOH 100 ㎕를 각각 첨가하여 멜라닌을 용해하였고, 405nm에서의 흡광도를 측정하여 멜라닌 량을 측정하였으며 실시예 17에 대한 결과를 도 2에 도시하였다. First, the mouse-derived malignant melanin tumor cell line B16F1 (KCLB 8007) was added to DMEM (Dulbecco's Modified Eagle's Medium) medium containing penicillin (100 IU / mL), streptomycin (100 g / mL), and 10% FBS (fetal bovine serum). Incubated in an incubator containing 5% carbon dioxide while maintaining 37 ° C. The obtained melanin tumor cells were seeded in 1 × 10 4 cells / well in a 24-well plate and cultured for 1 day. After incubation, the medium was removed, and then, in order to induce melanin synthesis, melanin synthesis was induced by adding 50 nM of alpha-MSH (melanocyte stimulating hormone; melanocyte stimulating hormone), except for the untreated group. The fermentation products obtained through the 32 to 32 were incubated for 3 days by adding DMEM medium added 0.1%, 0.5%, 1% and 800 μM kojic acid (positive control), respectively. The amount of synthesized melanin secreted by melanin tumor cells by each treatment group was visually checked and the change was photographed by a digital camera. The cells of each treatment group were collected and 100 μl of 10% DMSO (dimethyl sulfoxide) and 1N NaOH were collected. Each was added to dissolve the melanin, the absorbance at 405nm was measured to measure the amount of melanin and the results for Example 17 are shown in FIG.
2) 2) 타이로시네이즈Tyrosinase 발현 저해효과 Expression inhibitory effect
실시예 1 내지 3에 따른 발효물의 타이로시네이즈 발현 저해 효과를 알아보 기 위하여 하기와 같은 실험을 수행하였다.In order to determine the effect of inhibiting tyrosinase expression of the fermented products according to Examples 1 to 3, the following experiment was performed.
먼저, 마우스 유래 악성 멜라닌 종양 세포주 B16F1 (KCLB 8007)를 페니실린 (100 IU/mL), 스트렙토마이신 (100 g/mL Hyclone), 10% FBS (fetal bovine serum Hyclone)를 함유하는 DMEM (Dulbecco's Modified Eagle's Medium Hyclone) 배지에 넣고 37℃를 유지하며 5% 이산화탄소를 포함하는 배양기 내에서 배양하였다. 수득된 멜라닌 종양 세포를 6웰 플레이트에 1 × 105 세포/웰 (cells/well)에 접종 (seeding)하여 1일 배양하였다. 배양 후 배지를 제거한 다음, 멜라닌 합성을 유도시키기 위하여, alpha-MSH (melanocyte stimulating hormone; 멜라노사이트 자극 호르몬)을 비처리군을 제외하고 50 nM을 첨가하여 멜라닌 합성을 유도하였고, 동시에 유산균 파쇄 용해물을 각각 0.5%, 1% 가한 DMEM 배지를 첨가하여 1일간 배양하였다. 각 처리군의 세포를 수거한 후, SDS cell lysis buffer (2% SDS 첨가)로 세포를 용해시켜 용해물 (lysates)을 획득하고, 브래드-포드법 (Brad-ford)으로 총 단백질양을 정량하여 각 처리군의 총 단백질양을 보정하여, 웨스턴 시료를 제조하였다. 준비한 시료는 10% SDS PAGE에서 크기에 따라 단백질이 분리되었고, 이 후 PVDF 막 (membrane)으로 옮겨진 단백질은 항타이로시네이즈 항체를 1차 항체로 사용하여 엑스레이 필름에서 가시화되었다. 실시예 17에 의한 발효물에 대한 엑스레이 사진을 도 3에 도시하였다. 도 3을 참조하면, 본 발명에 따른 표고버섯 발효물의 경우 밴드가 보이지 않는다. 따라서, 타이로시네이즈가 생성되지 않는다는 것을 알 수 있으며, 이는 본 발명에 따른 발효물이 타이로시네이즈의 발현 저해효과가 우수하다는 것을 의미한다. First, the mouse-derived malignant melanin tumor cell line B16F1 (KCLB 8007) was replaced with DMEM (Dulbecco's Modified Eagle's Medium) containing penicillin (100 IU / mL), streptomycin (100 g / mL Hyclone), and 10% FBS (fetal bovine serum Hyclone). Hyclone) medium and maintained at 37 ℃ incubated in an incubator containing 5% carbon dioxide. The obtained melanin tumor cells were seeded in 1 × 10 5 cells / well in 6-well plates and cultured for 1 day. After incubation, the medium was removed, and then, in order to induce melanin synthesis, melanin synthesis was induced by adding 50 nM of alpha-MSH (melanocyte stimulating hormone) except for the untreated group, and at the same time, lactic acid bacteria lysate 0.5% and 1% were added to the DMEM medium and incubated for 1 day. After collecting the cells of each treatment group, lysates were obtained by lysing the cells with SDS cell lysis buffer (2% SDS addition), and the total protein amount was quantified by Brad-ford method. Western samples were prepared by correcting the total protein amount in each treatment group. The prepared samples were separated according to size on 10% SDS PAGE, and then the proteins transferred to PVDF membranes were visualized on X-ray films using antityrosinase antibodies as primary antibodies. An X-ray photograph of the fermentation product according to Example 17 is shown in FIG. 3. 3, in the case of shiitake mushroom fermentation product according to the present invention, no band is visible. Therefore, it can be seen that no tyrosinase is produced, which means that the fermentation product according to the present invention is excellent in inhibiting the expression of tyrosinase.
평가예Evaluation example 4. 4. 발효물의Fermented product 콜라겐 합성 촉진 효과(항노화 효능) Collagen synthesis promoting effect (anti-aging effect)
실시예 1 내지 32에 따른 발효물의 항노화 효과를 측정하기 위하여 발효물들의 사람 섬유아세포에서의 프로콜라겐 합성 촉진 효과를 알아보았다.In order to measure the anti-aging effect of the fermented products according to Examples 1 to 32, the effect of promoting collagen synthesis in human fibroblasts was examined.
먼저, 사람 섬유아세포 (normal human fibroblast)를 페니실린 (100 IU/mL), 스트렙토마이신 (100 g/mL), 10% FBS (fetal bovine serum)를 함유하는 DMEM (Dulbecco's Modified Eagle's Medium) 배지를 넣고 37℃를 유지하며 5% 이산화탄소를 포함하는 배양기 내에서 배양하였다. 수득된 섬유아세포를 6-웰 플레이트에 각 웰당 3× 105 개로 분주한 다음 세포배양조건에서 24시간 배양하였다. 배양 후 배지를 제거한 다음 0.05, 0.1, 0.2% 농도의 상기 실시예 1 내지 32 및 비교예 1 내지 32에서 수득된 각 발효물들 및 5, 10, 20 nM의 비타민C (양성대조군)를 무혈청 (serum-free) 배지 (DMEM)에서 24시간 동안 배양하였다. 각 처리군의 배양액을 수거하여 단백질 전기영동을 하였다. 이후, PVDF 막으로 옮겨진 단백질은 항-프로콜라겐 타입 항체 (anti-procollagen type1 antibody)를 1차 항체로 사용하여 엑스레이 필름에서 가시화되었으며, 상기에서 가시화한 콜라젠 밴드의 덴시티를 정량화한 후 이를 상호 비교하여 표 1의 항노화 효능란에 - (항노화효과 없슴), + (약간의 항노화효과를 보임), ++ (항노화효과가 우수함), +++ (항노화효과가 매우 우수함)으로 표시하였다. 한편, 본 발명의 실시예 1 내지 17에 대한 상기 엑스레이 사 진을 도 4 내지 6에 도시하였다. First, normal human fibroblasts were charged with DMEM (Dulbecco's Modified Eagle's Medium) medium containing penicillin (100 IU / mL), streptomycin (100 g / mL), and 10% FBS (fetal bovine serum). Culture was maintained in an incubator containing 5% carbon dioxide while maintaining the ℃. The obtained fibroblasts were dispensed into 6-well plates at 3 × 10 5 cells per well and incubated for 24 hours under cell culture conditions. After incubation, the medium was removed, and each fermented product obtained in Examples 1 to 32 and Comparative Examples 1 to 32 and 5, 10, and 20 nM of vitamin C (positive control group) at 0.05, 0.1, and 0.2% concentration were serum-free ( cultured in serum-free medium (DMEM) for 24 hours. The culture solution of each treatment group was collected and subjected to protein electrophoresis. Subsequently, the protein transferred to the PVDF membrane was visualized on an X-ray film using an
평가예Evaluation example 5. 5. 발효물의Fermented product 항산화 효과 Antioxidative effect
실시예 1 내지 32에 따른 항산화 효과를 측정하기 위하여 수퍼옥시드 디스뮤타제 (Superoxide dismutase:SOD) 유사 활성을 측정하였다.Superoxide dismutase (SOD) -like activity was measured to determine the antioxidant effect according to Examples 1 to 32.
먼저, 유산균 파쇄 용해물을 0.083, 0.83, 8.3%의 농도로 준비하고, 양성 대조군으로 사용할 SOD (Sigma, S-2515)를 0.1, 1, 10 U (unit)/ml의 농도로 준비하였다. SOD 활성도를 측정하기 위해 SOD assay kit (Dojindo molecular technologies, INC.)를 사용하였다. SOD는 유해한 활성산소(O2 -)를 무해한 과산화수소 (Hydrogen peroxide)로 전환시키는 대표적인 항산화 효소인데, kit에 포함되어 있는 잔틴 옥시다제 (xanthine oxidase)가 작용하여 활성 산소가 만들어졌을 때, 시료가 보유하는 SOD 활성도가 높을수록 만들어진 활성 산소가 WST-1이라는 기질을 WSH-1 formazan으로 변화시키지 않기 때문에 색의 변화가 없게 된다. 반면에, SOD 활성도가 없으면, 만들어진 활성산소에 의해 WSH-1이 WSH-1 formazan으로 쉽게 변화하기 때문에 색의 변화가 커지게 된다.First, lactic acid bacteria lysate was prepared at a concentration of 0.083, 0.83, 8.3%, and SOD (Sigma, S-2515) was prepared at a concentration of 0.1, 1, 10 U (unit) / ml to be used as a positive control. SOD assay kit (Dojindo molecular technologies, INC.) Was used to measure SOD activity. SOD is harmful free radicals (O 2 -) inde representative antioxidant enzyme that converts hydrogen peroxide (Hydrogen peroxide) harmless, as the xanthine oxidase (xanthine oxidase) that is included in the kit been radicals created by action, the sample is held The higher the SOD activity is, the more active oxygen does not change the substrate of WST-1 to WSH-1 formazan. On the other hand, if there is no SOD activity, the change in color is increased because WSH-1 easily changes to WSH-1 formazan by the produced active oxygen.
색 변화 관찰에 의해서 측정한 SOD 유사 활성도 결과를 항산화 효능으로서 하기 표 1에 나타내었으며, -(항산화효과 없슴), + (약간의 항산화효과를 보임), ++ (항산화효과가 우수함), +++ (항산화효과가 매우 우수함)으로 표시하였다. 한편, 실시예 1 내지 17의 발효물에 대한 SOD 유사 활성도 결과를 도 7 및 8에 도시 하였다.The results of SOD-like activity measured by observation of color change are shown in Table 1 as antioxidant efficacy,-(no antioxidant effect), + (shows some antioxidant effect), ++ (excellent antioxidant effect), ++ It is indicated as + (an excellent antioxidant effect). On the other hand, SOD-like activity results for the fermentations of Examples 1 to 17 are shown in Figures 7 and 8.
이하, 하기 조성에 따라서, 각각 비누형, 로션형, 크림형, 팩형, 미용액형의 제제들을 제조하였다.Hereinafter, according to the following composition, formulations of soap, lotion, cream, pack and cosmetic liquid forms were prepared, respectively.
제조예Production Example 1. One. 비누형Soap
실시예 1의 발효물 1.00Fermented product of Example 1 1.00
유지 75.00Maintenance 75.00
수산화나트륨 5.00Sodium Hydroxide 5.00
향료 10.00Spices 10.00
정제수 잔량Purified water level
(단위: 중량%)(Unit: weight%)
제조예Production Example 2. 로션형 2. Lotion Type
실시예 1의 발효물 3.00Fermentation of Example 1 3.00
L-아스코르빈산-2-인산마그네슘염 1.00L-ascorbic acid-2-magnesium phosphate salt 1.00
수용성 콜라겐 (1% 수용액) 1.00Water Soluble Collagen (1% Aqueous Solution) 1.00
시트르산나트륨 0.10Sodium Citrate 0.10
시트르산 0.05Citric Acid 0.05
감초 엑기스 0.20Licorice Extract 0.20
1,3-부틸렌글리콜 3.001,3-butylene glycol 3.00
정제수 잔량Purified water level
(단위: 중량%)(Unit: weight%)
제조예Production Example 3. 3. 크림형Cream
실시예 1의 발효물 1.00Fermented product of Example 1 1.00
폴리에틸렌글리콜모노스테아레이트 2.00 Polyethylene Glycol Monostearate 2.00
자기유화형 모노스테아르산글리세린 5.00Self-emulsifying glycerin monostearate 5.00
세틸알코올 4.00Cetyl Alcohol 4.00
스쿠알렌 6.00Squalene 6.00
트리2-에틸헥산글리세릴 6.00Tri2-ethylhexaneglyceryl 6.00
스핑고당지질 1.00Sphingolipids 1.00
1.3-부틸렌글리콜 7.001.3-butylene glycol 7.00
정제수 잔량Purified water level
(단위: 중량%)(Unit: weight%)
제조예Production Example 4. 4. 팩형Packed
실시예 1의 발효물 5.00Fermentation of Example 1 5.00
폴리비닐알코올 13.00Polyvinyl Alcohol 13.00
L-아스코르빈산-2-인산마그네슘염 1.00L-ascorbic acid-2-magnesium phosphate salt 1.00
라우로일히드록시프롤린 1.00Lauroylhydroxyproline 1.00
수용성 콜라겐 (1% 수용액) 2.00Water Soluble Collagen (1% Aqueous Solution) 2.00
1,3-부틸렌글리콜 3.001,3-butylene glycol 3.00
에탄올 5.00Ethanol 5.00
정제수 잔량Purified water level
(단위: 중량%)(Unit: weight%)
제조예Production Example 5. 5. 미용액형Cosmetic liquid type
실시예 1의 발효물 2.00Fermentation Example 2 2.00
히드록시에틸렌셀룰로오스 (2% 수용액) 12.00 Hydroxyethylene Cellulose (2% Aqueous Solution) 12.00
크산탄검 (2% 수용액) 2.00Xanthan gum (2% aqueous solution) 2.00
1,3-부틸렌글리콜 6.001,3-butylene glycol 6.00
진한 글리세린 4.00Dark Glycerin 4.00
히알루론산나트륨 (1% 수용액) 5.00Sodium Hyaluronate (1% aqueous solution) 5.00
정제수 잔량Purified water level
본 발명에 따라서 제조된 천연 식물소재 및 한약재 발효물은 안정성 및 안전성이 매우 뛰어나고 우수한 항노화, 항암, 항염, 면역 개선 등의 효능을 갖기 때문에 제약산업, 미용산업 및 식품산업 등과 같은 다양한 분야에 폭넓게 적용될 수 있다.The natural plant material and the herbal fermented product prepared according to the present invention are widely used in various fields such as pharmaceutical industry, beauty industry and food industry because they have excellent stability and safety and have excellent anti-aging, anti-cancer, anti-inflammatory and immunity improvement effects. Can be applied.
도 1은 본 발명에 따른 천연 식물소재 및 한약재의 발효방법에 대한 공정도를 개략적으로 도시한 도면이다.1 is a view schematically showing a process diagram for the fermentation method of natural plant material and herbal medicine according to the present invention.
도 2는 실시예 17에 의한 발효물의 멜라닌 합성저해효과를 도시한 그래프이다.Figure 2 is a graph showing the melanin synthesis inhibitory effect of the fermentation Example 17.
도 3은 실시예 17에 의한 발효물의 타이로시네이즈 발현억제효과를 확인할 수 있는 엑스레이 사진이다.3 is an X-ray photograph showing the effect of inhibiting the tyrosinase expression of the fermentation product of Example 17.
도 4은 본 발명의 실시예 1 내지 5에 따른 발효물의 콜라젠 합성 효과를 확인할 수 있는 엑스레이 사진이다. Figure 4 is an x-ray picture to confirm the collagen synthesis effect of the fermentation according to Examples 1 to 5 of the present invention.
도 5는 본 발명의 실시예 6 내지 11에 따른 발효물의 콜라젠 합성 효과를 확인할 수 있는 엑스레이 사진이다. Figure 5 is an x-ray picture to confirm the collagen synthesis effect of the fermentation according to Examples 6 to 11 of the present invention.
도 6는 본 발명의 실시예 12 내지 17에 따른 발효물의 콜라젠 합성 효과를 확인할 수 있는 엑스레이 사진이다. Figure 6 is an x-ray picture to confirm the collagen synthesis effect of the fermentation according to Examples 12 to 17 of the present invention.
도 7은 실시예 1 내지 8에 따른 발효물에 대한 SOD 유사 활성도 결과 그래프이다. 7 is a graph showing the results of SOD-like activity for fermentations according to Examples 1 to 8. FIG.
도 8은 실시예 9 내지 17에 따른 발효물에 대한 SOD 유사 활성도 결과 그래프이다. 8 is a graph showing the results of SOD-like activity for the fermentations according to Examples 9 to 17.
Claims (19)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070099512A KR100962587B1 (en) | 2007-10-02 | 2007-10-02 | A method for fermentation of natural plants and herbal medicines, a fermented product prepared therefrom and a paharmaceutical composition, a cosmetic compositon and a food composition comprising the product |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070099512A KR100962587B1 (en) | 2007-10-02 | 2007-10-02 | A method for fermentation of natural plants and herbal medicines, a fermented product prepared therefrom and a paharmaceutical composition, a cosmetic compositon and a food composition comprising the product |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090034241A KR20090034241A (en) | 2009-04-07 |
KR100962587B1 true KR100962587B1 (en) | 2010-06-11 |
Family
ID=40760252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070099512A KR100962587B1 (en) | 2007-10-02 | 2007-10-02 | A method for fermentation of natural plants and herbal medicines, a fermented product prepared therefrom and a paharmaceutical composition, a cosmetic compositon and a food composition comprising the product |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100962587B1 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101045011B1 (en) | 2010-10-22 | 2011-06-30 | 최재홍 | Method for preparing composition comprising fermented by using of hippophae rhamnoides l |
KR101211937B1 (en) * | 2012-09-18 | 2012-12-13 | 주식회사 들레네 | Functional fermented wild plants having anti-inflammatory effect using 101 wild plants extracts |
WO2012165843A3 (en) * | 2011-05-30 | 2013-03-28 | 한국 한의학 연구원 | Composition comprising herbal extracts or fermented products thereof having lactic acid bacteria for preventing or treating respiratory diseases |
KR101290795B1 (en) * | 2011-07-20 | 2013-07-29 | 주식회사 바이오랜드 | Manufacturing methods of fermentation bellflower increased aneffective ingredient |
KR101410791B1 (en) | 2012-08-28 | 2014-06-24 | 김영욱 | a fermentation medicinal herbs extract process |
KR101426501B1 (en) | 2012-10-11 | 2014-08-05 | 주식회사 한농로하스 | Fermentational Composition Comprising Portulaca Oleracea L. and Rice Bran and the Method of Manufacturing thereof |
KR20140103439A (en) * | 2013-02-18 | 2014-08-27 | 재단법인 대구테크노파크 | Composition for preventing, improving or treating allergic dermatitis comprising hot water extract or ferment extract of chestnut inner shell |
KR20160087113A (en) | 2015-01-13 | 2016-07-21 | 정다운 | Cosmetics containing flowers |
WO2016153270A3 (en) * | 2015-03-25 | 2016-11-17 | 이현구 | Method for preparing chrysanthemum family plant fermented composition, chrysanthemum family plant fermented composition prepared thereby, and pharmaceutical composition and health functional food for promoting neutralization of hepatotoxicity containing the same |
KR101740035B1 (en) | 2016-08-29 | 2017-05-25 | 이현구 | Prepration method of youngia denticulata houtt kitamura fermentation composition and youngia denticulata houtt kitamura fermentation composition using the same, pharmaceutical composition and functional health food for promoting reduction of liver toxicity including the same |
KR101794419B1 (en) * | 2015-12-10 | 2017-11-06 | (주)엠앤씨생명과학 | Osmotic enzyme fermentation natural liposome containing mushroom, process for the preparation thereof, and cosmetic, food or pharmaceutical composition comprising the same |
KR101817776B1 (en) * | 2017-05-30 | 2018-01-11 | (주)지에프씨 | Lespedeza cuneata G.Don Fermented extract Using Lactobacillus pentosus-GFC LP and Method for Preparing the Same |
KR20190081812A (en) * | 2017-12-29 | 2019-07-09 | 주식회사 티젠 농업회사법인 | Composition for improving immune system comprising a complex extract of Corni fructus, Eriobotryae Folium, and Olive leaf |
KR102036614B1 (en) * | 2018-07-19 | 2019-11-15 | 김경희 | Foundation composition having properties of blocking fine dust and low irritant and process for the preparation thereof |
KR102098577B1 (en) * | 2020-02-20 | 2020-04-08 | 농업회사법인주식회사천하제일한우 | Method of ripening and processing livestock for the distribution of livestock |
CN111465403A (en) * | 2017-12-06 | 2020-07-28 | 赫利世弥斯株式会社 | Herbal composition for preventing or treating prostatic hypertrophy |
KR20210030633A (en) | 2019-09-10 | 2021-03-18 | 농업회사법인제주생물자원㈜ | Cosmetic composition comprising extracts from rubus hongnoensis nakai or fractions thereof as an active ingredient |
KR20220016550A (en) * | 2020-08-03 | 2022-02-10 | 변한섭 | Cordyceps militaris hypha and hangover food thereby |
KR20220067980A (en) * | 2020-11-18 | 2022-05-25 | 한밭대학교 산학협력단 | Composition for antioxidant and immunity improvement activity containing natural extracts and health functional food containing the same |
KR20240112037A (en) | 2023-01-11 | 2024-07-18 | 산마을영농조합법인 | Method of producing balloon flower extract with increased platycodin D content |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100936457B1 (en) * | 2009-05-13 | 2010-01-13 | 주식회사 경희매니지먼트컴퍼니 | A making method of fermentational composition |
KR20110023367A (en) | 2009-08-31 | 2011-03-08 | (주)아모레퍼시픽 | Neck care methods and neck care kit comprising the same |
KR101127419B1 (en) * | 2009-10-29 | 2012-03-22 | 서범구 | Cosmetic composition comprising kaolin, colostrum and fermented oriental medicinal active liquid, and method of preparing the same |
KR101159260B1 (en) * | 2009-11-06 | 2012-06-25 | 농업회사법인주식회사 청산녹수 | manufacturing method of enzymatic degradation products of wild mulberry leaves and manufacturing method of rice wine using the same |
KR101663978B1 (en) * | 2009-11-30 | 2016-10-13 | (주)아모레퍼시픽 | Oral composition containing fermented herb extract for anti- gingivitis |
KR101238825B1 (en) * | 2010-02-10 | 2013-03-04 | 수성대학교 산학협력단 | The Composite make natural korean herb cosmetics from genseng saponin Rg1 and polia coccos ferment |
WO2011099665A1 (en) * | 2010-02-12 | 2011-08-18 | 주식회사 케이씨아이 | Antimicrobial composition containing extracts from natural ingredients, natural composite antiseptics, and method for manufacturing same |
KR101222708B1 (en) * | 2010-09-20 | 2013-01-15 | (주)라이프앤진 | Health foods composition for improving the skin |
KR101275971B1 (en) * | 2011-01-28 | 2013-06-17 | 조선대학교산학협력단 | Composition for antioxidation effect comprising sparassis crispa extract |
KR101096642B1 (en) * | 2011-04-05 | 2011-12-21 | 김중순 | The fermenting method of antlers which use mushroom concentrates |
KR101303295B1 (en) * | 2011-07-22 | 2013-09-03 | 이상록 | The cosmetic composition for promoting cell growth and recovery of distrupted skin containing the extracts of fermented Mistletoe, fermented Imperata cylindrica and fermented soybean |
KR101424180B1 (en) * | 2011-08-30 | 2014-07-28 | 양재찬 | A anti-inflammatory or skin moisturizing composition containing fermented plant extracts as an active ingredient |
KR101346693B1 (en) * | 2011-11-10 | 2013-12-31 | 청운대학교산학협력단 | Manufacturing method of composition of cosmetic using plant extract from codonopsis lanceolata and the composition of cosmetic |
KR101327810B1 (en) * | 2011-12-11 | 2013-11-08 | 박창하 | The method for manufacture of functional vinegar |
KR101402753B1 (en) * | 2012-06-05 | 2014-06-03 | 주식회사 유로코스텍 | Cosmetic composition from field waterdrop extract and its fermentation |
KR101422673B1 (en) * | 2012-10-05 | 2014-07-23 | 경희대학교 산학협력단 | Composition containing complex extracts for prevention or treatment of colitis |
KR20140054952A (en) * | 2012-10-30 | 2014-05-09 | 김세영 | Anti-inflammatory cosmetic composition containing mixture of fermented herbal extracts |
CN103263527B (en) * | 2013-05-09 | 2014-12-31 | 广西百通动物药业有限公司 | Chicken high fever disease prevention and treatment traditional Chinese medicine and preparation method thereof |
KR101581910B1 (en) * | 2013-08-29 | 2016-01-04 | 임실군 | Method for producing mushroom extract with enhanced antioxidative activity through lactobacillus fermentation |
CN103550372B (en) * | 2013-11-12 | 2014-10-08 | 张宏波 | Medicament for medical abortion |
KR101684601B1 (en) * | 2014-04-21 | 2016-12-09 | 씨에스팩 주식회사 | Green herbal disinfectant composition |
KR101479162B1 (en) * | 2014-07-09 | 2015-01-05 | 박양수 | Method of manufacturing cosmetic composition that contains phellinus linteus and natural conjugated materials with skin anti-aging effect |
CN104689065B (en) * | 2015-01-22 | 2018-04-10 | 武汉市第一医院 | Include charred RADIX ET RHIZOMA RHEI and Bletilla glucomannan medical composition and its use |
KR101667284B1 (en) * | 2015-05-12 | 2016-10-18 | 충남대학교산학협력단 | Cosmetics composition containing a fermented extract of black ginseng and herbal mixture |
KR101895111B1 (en) * | 2015-09-25 | 2018-09-04 | (주)엠앤씨생명과학 | Preparation method of osmotic enzyme fermentation product using mushroom, the fermentation product prepared thereby and cosmetic, food or pharmaceutical composition comprising the same |
KR101884897B1 (en) * | 2016-08-29 | 2018-08-02 | 주식회사 한국생명과학연구소 | Cosmetic composition having whitening activity comprising fermented extract of Angelica tenuissima |
KR101716489B1 (en) * | 2016-10-07 | 2017-03-27 | 주식회사 아미코스메틱 | Cosmetic composition containing sageretia theezans extracts |
KR101720740B1 (en) * | 2016-10-07 | 2017-04-10 | 주식회사 아미코스메틱 | Cosmetic composition containing carpinus cordata extracts |
KR101720741B1 (en) * | 2016-10-07 | 2017-03-29 | 주식회사 아미코스메틱 | Cosmetic composition comprising pourthiaea vilosa var. brunnea extract |
KR101851153B1 (en) * | 2016-11-16 | 2018-04-25 | 대한민국 | Manufacturing method of fermented rhemannia glutinosa and fermented rhemannia glutinosa manufactured by same method |
KR101854446B1 (en) * | 2017-01-10 | 2018-06-14 | 주식회사 아미코스메틱 | Cosmetic composition containing sageretia theezans extracts and spicule powder |
KR102046298B1 (en) * | 2017-04-11 | 2019-11-19 | 코스맥스 주식회사 | Composition for improving skin beauty comprising extract of fermented Lentinula edodes fermented with Aspergillus cristatus strain |
KR102004149B1 (en) * | 2017-04-11 | 2019-07-26 | 코스맥스 주식회사 | Composition for improving skin beauty comprising extract of fermented rice fermented with Aspergillus cristatus strain |
KR102019642B1 (en) * | 2017-04-11 | 2019-09-09 | 코스맥스 주식회사 | Composition for improving skin beauty comprising extract of fermented soybean fermented with Aspergillus cristatus strain |
KR101944183B1 (en) * | 2017-06-09 | 2019-01-30 | 계명대학교 산학협력단 | Method for manufacturing yeast starter containing apple pomace and Auricularia judae by mixed fermentation with lactic acid bacteria and yeast |
KR102412689B1 (en) * | 2017-09-12 | 2022-06-24 | 주식회사 유나이티드엑티브 | Functional fermented oil comprising medicinal herbs and preparation thereof |
KR102014602B1 (en) * | 2017-10-19 | 2019-08-29 | 주식회사 삼성인터네셔널 | Cosmetic composition for ameliorating chloasma |
KR102168791B1 (en) * | 2017-11-23 | 2020-10-22 | 경북대학교 산학협력단 | Pharmaceutical composition for inhibiting angiogenesis comprising bioconversion of Orostachys Japonicus extracts |
KR101984936B1 (en) * | 2017-12-06 | 2019-09-03 | 썬엔문(주) | Soap Composition for Exfoliating Skin using Microbial Agent and Manufacturing Method of thereof |
KR102117218B1 (en) * | 2018-01-18 | 2020-06-01 | 코스맥스 주식회사 | Composition for improving skin beauty comprising extract of fermented soybean fermented with Aspergillus cristatus strain |
KR102319686B1 (en) * | 2018-08-02 | 2021-11-01 | (주)아로마뉴텍 | Composition for skin whitening or anti-wrinkle comprising fermented extract of Ambrosia trifida and Annual fleabane |
KR102122914B1 (en) * | 2018-08-10 | 2020-07-01 | 한성호 | Food fermentation method |
KR102223579B1 (en) * | 2018-08-21 | 2021-03-08 | 오형근 | Lactic acid bacteria powder, sunsik composition, fermented milk, cheese, candy, male sunsik composition, natural preservative fermented plum manufacturing method, alcohol component decomposition and odor adsorption, removal method, and lactic acid bacteria dead cell growth method |
KR102017132B1 (en) * | 2018-10-11 | 2019-09-03 | 임승호 | Cosmetic composition comprising a mixed fermentation extract of cinnamomum verum and angelica dahurica |
KR102248056B1 (en) * | 2018-11-28 | 2021-05-03 | 황준환 | Cosmetic Composition containing Bottle Gourd Extract and Manufacturing method of thereof |
KR102054100B1 (en) * | 2019-03-06 | 2020-01-22 | 휘조우 맨내이 바이오로지컬 테크놀로지 컴퍼니 리미티드 | Cosmetic composition containing fermented extract of roots |
KR102108912B1 (en) * | 2019-04-18 | 2020-05-11 | 이에스더 | Composition for improving skin moisturizing and inflammation |
KR102356339B1 (en) * | 2019-07-11 | 2022-01-28 | (주) 나우코스 | Cosmetic composition comprising fermented extract of Scutellaria baicalensis for inhibiting skin damage by ultraviolet |
KR102202554B1 (en) * | 2019-07-23 | 2021-01-14 | 주식회사 현대바이오랜드 | Skin whitening cosmetic composition with the extract of Saururus chinensis leaf, the extract of Grape seed, the extract of Portulaca oleracea and rice fermented product |
KR102258859B1 (en) * | 2019-08-16 | 2021-06-04 | (주)나우코스 | Method of producing a ferment extract using the Centella asiatica and cosmetic composition using the same |
KR102418703B1 (en) * | 2020-01-23 | 2022-07-08 | (주)에스디생명공학 | Composition for Improving for Preventing or Treating in Skin Wrinkle and Atopic Dermatitis Comprising Extract of Thymus vulgaris Fermented by Lactic Acid Bacteria as Active Ingredient |
CN111454993B (en) * | 2020-04-15 | 2021-01-15 | 武汉森澜生物科技有限公司 | Semen cassiae fermentation product and application thereof |
KR102422924B1 (en) * | 2020-06-03 | 2022-07-21 | (주)나우코스 | Cosmetic composition comprising mixture of fermentation extracts of olea europaea leaf for alleviating skin inflammation or skin hyperpigmentation by yellow sand or fine dust |
KR102544792B1 (en) * | 2020-06-17 | 2023-06-16 | 주식회사 에스겔코스메틱 | Composition Comprising Complex Extract of seaweeds Fermented by Lactobacillus Brevis with Anti-Wrinkling and Elasticity, Antioxidant, and Skin Hydration Property as Active Ingredient |
KR102216605B1 (en) * | 2020-08-11 | 2021-02-17 | 재단법인춘천바이오산업진흥원 | Method for increasing production of luteolin and luteolin-7-glucoside using microbial fermentation |
WO2022098211A1 (en) * | 2020-11-09 | 2022-05-12 | 주식회사 엑티브온 | Cosmetic composition comprising fermented acorus calamus l. and preparation method therefor |
KR102233897B1 (en) * | 2020-11-18 | 2021-03-31 | (주)엔젤엠엘 | Manufacturing method of anti-bacterial handle and anti-bacterial handle manufactured thereby |
KR102261115B1 (en) * | 2020-12-04 | 2021-06-04 | 주식회사 네오캠코리아 | Cosmetic composition with the extract of Salicornia herbacea L., the extract of Liriope platyphylla and the extract of Eleutherococcus senticosus for improving skin wrinkle |
KR102559627B1 (en) * | 2020-12-28 | 2023-07-26 | 주식회사 프로앱텍 | A composition for preventing bone disease and improving bone function, using Lactobacillus fermented pumpkin tendril extract and manufacturing method thereof |
KR102538762B1 (en) * | 2020-12-31 | 2023-06-02 | (주)뷰티언스 | Method for producing a composition containing fermented ephedra |
KR102678441B1 (en) * | 2021-05-25 | 2024-06-28 | 주식회사 더가든오브내추럴솔루션 | Fermented extract complex Composite of wild-type Lycii fructus, Eclipta prostrate and Phelloclendri cortex, and Cosmetic Composition comprising of the same |
KR102614707B1 (en) | 2021-05-28 | 2023-12-15 | 주식회사 인투바이오 | Method for preparing chlorella vulgaris extract containing high content of amino acids and cosmetic composition comprising the same |
KR102657007B1 (en) | 2021-07-09 | 2024-04-16 | 김주영 | Composion of fermented oriental herb, method of manufacturing the same and use of the same |
KR102684122B1 (en) * | 2021-08-13 | 2024-07-12 | 선문대학교 산학협력단 | Compositions containing Chaga fermentation extract |
KR102538404B1 (en) * | 2021-10-05 | 2023-06-01 | 서정한 | Manufacturing method of omijaju using Rhizopus strain and omijaju produced through the same |
KR102440743B1 (en) * | 2021-10-07 | 2022-09-06 | 주식회사 아이디플라코스메틱 | Cosmetic composition for reducing skin wrinkles, improving skin elasticity and antioxidation containing the complex extracts of Diospyros Kaki Leaf, Scutellaria Baicalensis, Cimicifuga Dahurica and Sophora Japonica Flower |
WO2023149769A1 (en) * | 2022-02-07 | 2023-08-10 | 전동욱 | Composition for preventing, ameliorating or treating uv-induced skin damage and method for protecting skin using same |
CN116407470A (en) * | 2022-03-30 | 2023-07-11 | 山东花物堂生物科技有限公司 | Plant composition and preparation method and application thereof |
KR102517944B1 (en) * | 2022-04-06 | 2023-04-06 | 한경수 | Pharmaceutical composition and health functional food for prevention or treatment of cancer containing complex medicinal herb extracts |
CN114774473B (en) * | 2022-04-25 | 2024-07-09 | 广州千物百草生物科技有限公司 | Fermentation method for fermenting plant extract with lactobacillus |
KR20240064160A (en) | 2022-11-04 | 2024-05-13 | 한국한의약진흥원 | Bioconversion fraction of Lugen extract with increased anti-inflammatory activity and lipid metabolism regulation activity and method for producing the same |
CN116019747B (en) * | 2023-02-01 | 2023-11-14 | 广州优科生物科技有限公司 | Preparation method of guava fermentation product, product and application thereof |
KR102621129B1 (en) * | 2023-03-20 | 2024-01-08 | 김도현 | Natural cosmetic composition using grains and herbal medicines |
KR102616141B1 (en) * | 2023-08-18 | 2023-12-19 | 정지영 | Vegan cosmetic composition containing eight complex to improve skin inflammation and skin itchiness |
KR102616144B1 (en) * | 2023-09-20 | 2023-12-19 | 정지영 | Cosmetic composition for improving skin wrinkles containing eight complex |
KR102686879B1 (en) * | 2024-03-15 | 2024-07-22 | (주) 라이프위드코퍼레이션 | Wrinkle and pore improvement composition containing retinol and collagen active ingredients and manufacturing method thereof |
KR102686874B1 (en) * | 2024-03-15 | 2024-07-22 | (주) 라이프위드코퍼레이션 | Cosmetic composition containing five whitening active ingredients and manufacturing method thereof |
KR102686867B1 (en) * | 2024-03-15 | 2024-07-22 | (주) 라이프위드코퍼레이션 | Cosmetic composition containing active ingredients for improving sebum and acne and manufacturing method thereof |
CN117959374B (en) * | 2024-03-26 | 2024-07-19 | 广州中医药大学(广州中医药研究院) | Preparation method and application of medicinal and edible traditional Chinese medicine health care moxibustion fumigation composition |
-
2007
- 2007-10-02 KR KR1020070099512A patent/KR100962587B1/en active IP Right Grant
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101045011B1 (en) | 2010-10-22 | 2011-06-30 | 최재홍 | Method for preparing composition comprising fermented by using of hippophae rhamnoides l |
WO2012165843A3 (en) * | 2011-05-30 | 2013-03-28 | 한국 한의학 연구원 | Composition comprising herbal extracts or fermented products thereof having lactic acid bacteria for preventing or treating respiratory diseases |
KR101290795B1 (en) * | 2011-07-20 | 2013-07-29 | 주식회사 바이오랜드 | Manufacturing methods of fermentation bellflower increased aneffective ingredient |
KR101410791B1 (en) | 2012-08-28 | 2014-06-24 | 김영욱 | a fermentation medicinal herbs extract process |
KR101211937B1 (en) * | 2012-09-18 | 2012-12-13 | 주식회사 들레네 | Functional fermented wild plants having anti-inflammatory effect using 101 wild plants extracts |
KR101426501B1 (en) | 2012-10-11 | 2014-08-05 | 주식회사 한농로하스 | Fermentational Composition Comprising Portulaca Oleracea L. and Rice Bran and the Method of Manufacturing thereof |
KR20140103439A (en) * | 2013-02-18 | 2014-08-27 | 재단법인 대구테크노파크 | Composition for preventing, improving or treating allergic dermatitis comprising hot water extract or ferment extract of chestnut inner shell |
KR101595959B1 (en) * | 2013-02-18 | 2016-02-19 | 재단법인 대구테크노파크 | Composition for preventing, improving or treating allergic dermatitis comprising hot water extract or ferment extract of chestnut inner shell |
KR20160087113A (en) | 2015-01-13 | 2016-07-21 | 정다운 | Cosmetics containing flowers |
WO2016153270A3 (en) * | 2015-03-25 | 2016-11-17 | 이현구 | Method for preparing chrysanthemum family plant fermented composition, chrysanthemum family plant fermented composition prepared thereby, and pharmaceutical composition and health functional food for promoting neutralization of hepatotoxicity containing the same |
KR101794419B1 (en) * | 2015-12-10 | 2017-11-06 | (주)엠앤씨생명과학 | Osmotic enzyme fermentation natural liposome containing mushroom, process for the preparation thereof, and cosmetic, food or pharmaceutical composition comprising the same |
KR101740035B1 (en) | 2016-08-29 | 2017-05-25 | 이현구 | Prepration method of youngia denticulata houtt kitamura fermentation composition and youngia denticulata houtt kitamura fermentation composition using the same, pharmaceutical composition and functional health food for promoting reduction of liver toxicity including the same |
KR101817776B1 (en) * | 2017-05-30 | 2018-01-11 | (주)지에프씨 | Lespedeza cuneata G.Don Fermented extract Using Lactobacillus pentosus-GFC LP and Method for Preparing the Same |
CN111465403A (en) * | 2017-12-06 | 2020-07-28 | 赫利世弥斯株式会社 | Herbal composition for preventing or treating prostatic hypertrophy |
KR20190081812A (en) * | 2017-12-29 | 2019-07-09 | 주식회사 티젠 농업회사법인 | Composition for improving immune system comprising a complex extract of Corni fructus, Eriobotryae Folium, and Olive leaf |
KR102007870B1 (en) | 2017-12-29 | 2019-08-07 | 주식회사 티젠 농업회사법인 | Composition for improving immune system comprising a complex extract of Corni fructus, Eriobotryae Folium, and Olive leaf |
KR102036614B1 (en) * | 2018-07-19 | 2019-11-15 | 김경희 | Foundation composition having properties of blocking fine dust and low irritant and process for the preparation thereof |
KR20210030633A (en) | 2019-09-10 | 2021-03-18 | 농업회사법인제주생물자원㈜ | Cosmetic composition comprising extracts from rubus hongnoensis nakai or fractions thereof as an active ingredient |
KR102098577B1 (en) * | 2020-02-20 | 2020-04-08 | 농업회사법인주식회사천하제일한우 | Method of ripening and processing livestock for the distribution of livestock |
KR20220016550A (en) * | 2020-08-03 | 2022-02-10 | 변한섭 | Cordyceps militaris hypha and hangover food thereby |
KR102468614B1 (en) * | 2020-08-03 | 2022-11-17 | 변한섭 | Cultivation method of cordyceps militaris hypha and hangover food therewith |
KR20220067980A (en) * | 2020-11-18 | 2022-05-25 | 한밭대학교 산학협력단 | Composition for antioxidant and immunity improvement activity containing natural extracts and health functional food containing the same |
KR102513040B1 (en) * | 2020-11-18 | 2023-03-21 | 한밭대학교 산학협력단 | Composition for antioxidant and immunity improvement activity containing natural extracts and health functional food containing the same |
KR20240112037A (en) | 2023-01-11 | 2024-07-18 | 산마을영농조합법인 | Method of producing balloon flower extract with increased platycodin D content |
Also Published As
Publication number | Publication date |
---|---|
KR20090034241A (en) | 2009-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100962587B1 (en) | A method for fermentation of natural plants and herbal medicines, a fermented product prepared therefrom and a paharmaceutical composition, a cosmetic compositon and a food composition comprising the product | |
KR20090123458A (en) | A method for fermentation of natural plants or herbal medicines, a fermented product prepared therefrom and a cosmetic composition, a food composition and a pharmaceutical composition comprising the same | |
KR100972116B1 (en) | Method of producing fermentation of herbal medicine, the fermentation produced thereby, and food comprising the fermentation | |
KR101464745B1 (en) | Compositions comprising fermentative extract of Orchidaceae for improving functions of skin | |
KR101451981B1 (en) | Compositions comprising fermentative extract of Orchidaceae for improving functions of skin | |
KR20100101258A (en) | Methods for fermentation of natural plants or herbal medicines and fermented products using the same methods | |
KR101566320B1 (en) | Cosmetic composition comprising an Impatiens balsamina L, Maca, Rosa multiflora Thunberg, Eryobotrya japonica and Pachyrrhizus erosus Complex-fermented extract | |
KR20090002677A (en) | Cosmetic composition having antioxidation activity | |
KR101914344B1 (en) | A moisturizing and anti-wrinkle cosmetic composition comprising fermented barley, fermented pear juice, fermented soybeans and fermented pomegranate extract and the method preparation of thereof | |
KR102298700B1 (en) | Facturing method of functional liquefied healthfoods using Gastroia elata Blume and Polygonum multiflorum Thunberg | |
KR102051939B1 (en) | Manufacturing method and cosmetic ingredient using Dendropanax morbifera Lev extraction fluid | |
KR101914345B1 (en) | A moisturizing and anti-wrinkle cosmetic composition comprising fermented soybean, fermented rice, fermented potato, fermented ginseng and fermented adlay extract and preparation method of thereof | |
KR20080008491A (en) | Fermented rubus coreanus miq. and the composition containing thereof | |
KR102594733B1 (en) | Cosmetic composition for improving melasma, freckles, whitenings and wrinkle comprising extract of fermented chestnut inner shell, angelica dahurica, portulace oleracea, armeniacae and mori dadicis cortex and preparation method thereof | |
KR100898311B1 (en) | Cosmetic composition containing extract of mixed fermentation with soy bean milk | |
CN211751169U (en) | Rutaceae plant fermentation liquor particle structure with functions of reducing fat, losing weight, resisting aging and resisting wrinkles | |
KR102355143B1 (en) | Method for preparing fermentated ziziphus jujuba seed | |
KR102620811B1 (en) | Red centella asiatica fermented with monascus and its use | |
KR102507651B1 (en) | Fermented Stauntonia hexaphylla for hangover relief, alcoholic liver disease or liver function improvement using fermented enzyme complex solution containing traditional brewery yeast and its manufacturing method | |
KR102071218B1 (en) | Anti-aging and anti-wrinkle of skin improving cosmetic composition comprising extracts of Moschus, Angelica gigas Nakai, Cornus officinalis, Cervi Parvum Cornu and Phellinus linteus, Ganoderma Lucidum, Inonotus obliquus, Grifola Frondosa, Sparassis crispa | |
KR100838705B1 (en) | Mushroom fermentation, preparing method and use thereof | |
KR20110044966A (en) | Compositions for antioxidation | |
KR20100101257A (en) | Compositions for uv protection, anti-inflammatory, antioxidation and antiaging | |
JP7382622B2 (en) | Composition | |
KR100697655B1 (en) | Fermented guava composition safty-established by microbial fermentation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B601 | Maintenance of original decision after re-examination before a trial | ||
E801 | Decision on dismissal of amendment | ||
S901 | Examination by remand of revocation | ||
GRNO | Decision to grant (after opposition) | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130523 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20140602 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20150602 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20170601 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20180531 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190530 Year of fee payment: 10 |